ITEM 1. FINANCIAL STATEMENTS
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited) | | | | | | | | | | | |
| As of |
$ in thousands, except share amounts | March 31, 2023 | | December 31, 2022 |
ASSETS | |
Mortgage-backed securities, at fair value (including pledged securities of $5,085,592 and $4,439,583, respectively) | 5,447,143 | | | 4,791,893 | |
| | | |
Cash and cash equivalents | 101,834 | | | 175,535 | |
Restricted cash | 127,038 | | | 103,246 | |
Due from counterparties | 2,983 | | | 1,584 | |
Investment related receivable | 23,239 | | | 22,744 | |
Derivative assets, at fair value | 3,416 | | | 662 | |
Other assets | 1,719 | | | 1,731 | |
Total assets | 5,707,372 | | | 5,097,395 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | | | |
Liabilities: | | | |
Repurchase agreements | 4,814,700 | | | 4,234,823 | |
Derivative liabilities, at fair value | 12,291 | | | 2,079 | |
Dividends payable | 16,658 | | | 25,162 | |
| | | |
Accrued interest payable | 22,381 | | | 20,546 | |
Collateral held payable | 1,571 | | | 4,892 | |
Accounts payable and accrued expenses | 1,917 | | | 1,365 | |
Due to affiliate | 3,739 | | | 4,453 | |
Total liabilities | 4,873,257 | | | 4,293,320 | |
Commitments and contingencies (See Note 14): | | | |
Stockholders' equity: | | | |
Preferred Stock, par value $0.01 per share; 50,000,000 shares authorized: | | | |
7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock: 4,537,634 shares issued and outstanding ($113,441 aggregate liquidation preference) | 109,679 | | | 109,679 | |
7.50% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock: 7,816,470 shares issued and outstanding ($195,412 aggregate liquidation preference) | 189,028 | | | 189,028 | |
Common Stock, par value $0.01 per share; 67,000,000 shares authorized; 41,647,244 and 38,710,916 shares issued and outstanding, respectively | 416 | | | 387 | |
Additional paid in capital | 3,937,487 | | | 3,901,562 | |
Accumulated other comprehensive income | 5,904 | | | 10,761 | |
Retained earnings (distributions in excess of earnings) | (3,408,399) | | | (3,407,342) | |
Total stockholders’ equity | 834,115 | | | 804,075 | |
Total liabilities and stockholders' equity | 5,707,372 | | | 5,097,395 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands, except share data | 2023 | | 2022 | | | | |
Interest income | | | | | | | |
Mortgage-backed and other securities | 69,287 | | | 41,637 | | | | | |
Commercial loan | — | | | 537 | | | | | |
Total interest income | 69,287 | | | 42,174 | | | | | |
Interest expense | | | | | | | |
Repurchase agreements (1) | 49,726 | | | (2,104) | | | | | |
Total interest expense | 49,726 | | | (2,104) | | | | | |
Net interest income | 19,561 | | | 44,278 | | | | | |
Other income (loss) | | | | | | | |
Gain (loss) on investments, net | 51,956 | | | (504,388) | | | | | |
| | | | | | | |
Equity in earnings (losses) of unconsolidated ventures | 2 | | | 71 | | | | | |
Gain (loss) on derivative instruments, net | (44,895) | | | 238,860 | | | | | |
Other investment income (loss), net | (93) | | | 55 | | | | | |
Total other income (loss) | 6,970 | | | (265,402) | | | | | |
Expenses | | | | | | | |
Management fee – related party | 2,979 | | | 5,274 | | | | | |
General and administrative | 2,089 | | | 2,024 | | | | | |
Total expenses | 5,068 | | | 7,298 | | | | | |
Net income (loss) | 21,463 | | | (228,422) | | | | | |
Dividends to preferred stockholders | (5,862) | | | (8,394) | | | | | |
Net income (loss) attributable to common stockholders | 15,601 | | | (236,816) | | | | | |
Earnings (loss) per share: | | | | | | | |
Net income (loss) attributable to common stockholders | | | | | | | |
Basic | 0.39 | | | (7.18) | | | | | |
Diluted | 0.39 | | | (7.18) | | | | | |
(1)Negative interest expense on repurchase agreements in 2022 is due to amortization of net deferred gains on de-designated interest rate swaps that exceeds current period interest expense on repurchase agreements. For further information on amortization of amounts classified in accumulated other comprehensive income before we discontinued hedge accounting, see Note 8 - "Derivatives and Hedging Activities" and Note 12 - "Stockholders' Equity".
The accompanying notes are an integral part of these condensed consolidated financial statements.
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Net income (loss) | 21,463 | | | (228,422) | | | | | |
Other comprehensive income (loss): | | | | | | | |
Unrealized gain (loss) on mortgage-backed securities, net | (476) | | | (2,421) | | | | | |
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense | (4,494) | | | (5,196) | | | | | |
Currency translation adjustments on investment in unconsolidated venture | (10) | | | (200) | | | | | |
Reclassification of currency translation loss on investment in unconsolidated venture to other investment income (loss), net | 123 | | | — | | | | | |
Total other comprehensive income (loss) | (4,857) | | | (7,817) | | | | | |
Comprehensive income (loss) | 16,606 | | | (236,239) | | | | | |
Dividends to preferred stockholders | (5,862) | | | (8,394) | | | | | |
Comprehensive income (loss) attributable to common stockholders | 10,744 | | | (244,633) | | | | | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
For the three months ended March 31, 2023 and 2022
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | Additional Paid in Capital | | Accumulated Other Comprehensive Income (Loss) | | Retained Earnings (Distributions in excess of earnings) | | Total Stockholders’ Equity |
| Series B Preferred Stock | | Series C Preferred Stock | | | |
$ in thousands, except share amounts | | | Common Stock | |
Shares | | Amount | | Shares | | Amount | | Shares | | Amount | | | | |
Balance at December 31, 2022 | 4,537,634 | | | 109,679 | | | 7,816,470 | | | 189,028 | | | 38,710,916 | | | 387 | | | 3,901,562 | | | 10,761 | | | (3,407,342) | | | 804,075 | |
Net income (loss) | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 21,463 | | | 21,463 | |
Other comprehensive income (loss) | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (4,857) | | | — | | | (4,857) | |
Proceeds from issuance of common stock, net of offering costs | — | | | — | | | — | | | — | | | 2,930,069 | | | 29 | | | 35,763 | | | — | | | — | | | 35,792 | |
Stock awards | — | | | — | | | — | | | — | | | 6,259 | | | — | | | — | | | — | | | — | | | — | |
Common stock dividends | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (16,658) | | | (16,658) | |
Preferred stock dividends | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (5,862) | | | (5,862) | |
Amortization of equity-based compensation | — | | | — | | | — | | | — | | | — | | | — | | | 162 | | | — | | | — | | | 162 | |
Balance at March 31, 2023 | 4,537,634 | | | 109,679 | | | 7,816,470 | | | 189,028 | | | 41,647,244 | | | 416 | | | 3,937,487 | | | 5,904 | | | (3,408,399) | | | 834,115 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | Additional Paid in Capital | | Accumulated Other Comprehensive Income (Loss) | | Retained Earnings (Distributions in excess of earnings) | | Total Stockholders’ Equity |
| Series B Preferred Stock | | Series C Preferred Stock | | | |
$ in thousands, except share amounts | | | Common Stock | |
Shares | | Amount | | Shares | | Amount | | Shares | | Amount | | | | |
Balance at December 31, 2021 | 6,200,000 | | | 149,860 | | | 11,500,000 | | | 278,108 | | | 32,987,478 | | | 330 | | | 3,819,375 | | | 37,286 | | | (2,882,824) | | | 1,402,135 | |
Net income (loss) | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (228,422) | | | (228,422) | |
Other comprehensive income (loss) | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (7,817) | | | — | | | (7,817) | |
| | | | | | | | | | | | | | | | | | | |
Stock awards | — | | | — | | | — | | | — | | | 4,315 | | | — | | | — | | | — | | | — | | | — | |
Common stock dividends | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (29,693) | | | (29,693) | |
Preferred stock dividends | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (8,394) | | | (8,394) | |
Amortization of equity-based compensation | — | | | — | | | — | | | — | | | — | | | — | | | 138 | | | — | | | — | | | 138 | |
Balance at March 31, 2022 | 6,200,000 | | | 149,860 | | | 11,500,000 | | | 278,108 | | | 32,991,793 | | | 330 | | | 3,819,513 | | | 29,469 | | | (3,149,333) | | | 1,127,947 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited) | | | | | | | | | | | |
| Three Months Ended March 31, |
$ in thousands | 2023 | | 2022 |
Cash Flows from Operating Activities | | | |
Net income (loss) | 21,463 | | | (228,422) | |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | |
Amortization of mortgage-backed and other securities premiums and (discounts), net | 1,938 | | | 4,813 | |
Realized and unrealized (gain) loss on derivative instruments, net | 99,359 | | | (237,576) | |
(Gain) loss on investments, net | (51,956) | | | 504,388 | |
| | | |
(Gain) loss from investments in unconsolidated ventures in excess of distributions received | (2) | | | 34 | |
Other amortization | (4,332) | | | (5,058) | |
Loss on foreign currency translation | 123 | | | — | |
Changes in operating assets and liabilities: | | | |
(Increase) decrease in operating assets | (1,025) | | | 1,875 | |
Increase (decrease) in operating liabilities | 1,596 | | | 82 | |
Net cash provided by (used in) operating activities | 67,164 | | | 40,136 | |
Cash Flows from Investing Activities | | | |
Purchase of mortgage-backed securities | (1,449,957) | | | (7,602,660) | |
Purchase of U.S. Treasury securities | — | | | (502,288) | |
Distributions from investments in unconsolidated ventures, net | 40 | | | 7,388 | |
Principal payments from mortgage-backed securities | 61,089 | | | 168,316 | |
Proceeds from sale of mortgage-backed securities | 783,883 | | | 8,754,469 | |
| | | |
Settlement (termination) of forwards, swaps, and TBAs, net | (91,900) | | | 283,429 | |
Net change in due from counterparties and collateral held payable on derivative instruments | (49) | | | (38,829) | |
Net cash provided by (used in) investing activities | (696,894) | | | 1,069,825 | |
Cash Flows from Financing Activities | | | |
Proceeds from issuance of common stock | 35,792 | | | — | |
| | | |
| | | |
| | | |
Proceeds from repurchase agreements | 9,318,669 | | | 23,329,788 | |
Principal repayments of repurchase agreements | (8,738,792) | | | (24,480,202) | |
Net change in due from counterparties and collateral held payable on repurchase agreements | (4,671) | | | (979) | |
Payments of deferred costs | (153) | | | (4) | |
Payments of dividends | (31,024) | | | (38,083) | |
Net cash provided by (used in) financing activities | 579,821 | | | (1,189,480) | |
Net change in cash, cash equivalents and restricted cash | (49,909) | | | (79,519) | |
Cash, cash equivalents and restricted cash, beginning of period | 278,781 | | | 577,052 | |
Cash, cash equivalents and restricted cash, end of period | 228,872 | | | 497,533 | |
Supplement Disclosure of Cash Flow Information | | | |
Interest paid | 52,386 | | | 2,771 | |
Non-cash Investing and Financing Activities Information | | | |
Net change in unrealized gain (loss) on mortgage-backed securities classified as available-for-sale | 476 | | | (2,421) | |
Dividends declared not paid | 16,658 | | | 29,693 | |
Net change in investment related receivable (payable) | (723) | | | 15 | |
| | | |
Net change in foreign currency translation adjustment recorded in accumulated other comprehensive income | (113) | | | 200 | |
| | | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 – Organization and Business Operations
Invesco Mortgage Capital Inc. (the “Company” or “we”) is a Maryland corporation primarily focused on investing in, financing and managing mortgage-backed securities ("MBS”) and other mortgage-related assets.
As of March 31, 2023, we were invested in:
•residential mortgage-backed securities (“RMBS”) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association (“Ginnie Mae”), or a federally chartered corporation such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”) (collectively “Agency RMBS”);
•commercial mortgage-backed securities (“CMBS”) that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency CMBS”);
•RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency RMBS”); and
•other real estate-related financing arrangements.
During the periods presented in these condensed consolidated financial statements, we also invested in:
•a commercial mortgage loan; and
•U.S. Treasury securities.
We conduct our business through IAS Operating Partnership L.P. (the “Operating Partnership”) and have one operating segment. We are externally managed and advised by Invesco Advisers, Inc. (our “Manager”), a registered investment adviser and an indirect, wholly-owned subsidiary of Invesco Ltd. (“Invesco”), a leading independent global investment management firm.
We elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the provisions of the Internal Revenue Code of 1986. To maintain our REIT qualification, we are generally required to distribute at least 90% of our REIT taxable income to our stockholders annually. We operate our business in a manner that permits our exclusion from the “Investment Company” definition under the Investment Company Act of 1940, as amended (the “1940 Act”).
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
For all periods presented, common shares and per common share amounts have been adjusted on a retroactive basis to reflect our one-for-ten reverse stock split, which was effected following the close of business on June 3, 2022.
Certain disclosures included in our Annual Report on Form 10-K are not required to be included on an interim basis in our quarterly reports on Form 10-Q. We have condensed or omitted these disclosures. Therefore, this Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022.
Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and consolidate the financial statements of the Company and its controlled subsidiaries. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for a fair statement of our financial condition and results of operations for the periods presented.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Examples of estimates include, but are not limited to, estimates of the fair values of financial instruments, interest income on mortgage-backed securities and allowances for credit losses. Actual results may differ from those estimates.
Significant Accounting Policies
There have been no changes to our accounting policies included in Note 2 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2022.
Note 3 – Variable Interest Entities ("VIEs")
Our maximum risk of loss in VIEs in which we are not the primary beneficiary at March 31, 2023 is presented in the table below.
| | | | | | | | | | | |
$ in thousands | Carrying Amount | | Company's Maximum Risk of Loss |
Non-Agency CMBS | 36,624 | | | 36,624 | |
Non-Agency RMBS | 8,319 | | | 8,319 | |
Investments in unconsolidated ventures | 504 | | | 504 | |
Total | 45,447 | | | 45,447 | |
Refer to Note 4 - "Mortgage-Backed Securities" and Note 5 - "Other Assets" for additional details regarding these investments.
Note 4 – Mortgage-Backed Securities
The following tables summarize our MBS portfolio by asset type as of March 31, 2023 and December 31, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
March 31, 2023 | | | | | | | | | | | | | |
$ in thousands | Principal/ Notional Balance | | Unamortized Premium (Discount) | | Amortized Cost | | | | Unrealized Gain/ (Loss), net | | Fair Value | | Period- end Weighted Average Yield (1) |
| | | | | | | | | | | | | |
30 year fixed-rate Agency RMBS | 5,356,642 | | | (157,394) | | | 5,199,248 | | | | | 121,694 | | | 5,320,942 | | | 5.15 | % |
| | | | | | | | | | | | | |
Agency-CMO (2) | 608,132 | | | (527,420) | | | 80,712 | | | | | 546 | | | 81,258 | | | 9.74 | % |
Non-Agency CMBS | 38,652 | | | (1,181) | | | 37,471 | | | | | (847) | | | 36,624 | | | 8.35 | % |
Non-Agency RMBS (3)(4)(5) | 301,262 | | | (293,407) | | | 7,855 | | | | | 464 | | | 8,319 | | | 8.05 | % |
Total | 6,304,688 | | | (979,402) | | | 5,325,286 | | | | | 121,857 | | | 5,447,143 | | | 5.24 | % |
(1)Period-end weighted average yield is based on amortized cost as of March 31, 2023 and incorporates future prepayment and loss assumptions when appropriate.
(2)All Agency collateralized mortgage obligations (“Agency-CMO”) are interest-only securities (“Agency IO”).
(3)Non-Agency RMBS is 69.1% fixed rate, 30.1% variable rate, and 0.8% floating rate based on fair value. Coupon payments on variable rate investments are based upon changes in the underlying hybrid adjustable-rate mortgage (“ARM”) loan coupons, while coupon payments on floating rate investments are based upon a spread to a reference index.
(4)Of the total discount in non-Agency RMBS, $2.1 million is non-accretable calculated using the principal/notional balance and based on estimated future cash flows of the securities.
(5)Non-Agency RMBS includes interest-only securities ("non-Agency IO") which represent 97.1% of principal/notional balance, 40.5% of amortized cost and 34.8% of fair value.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, 2022 | | | | | | | | | | | | |
$ in thousands | Principal/Notional Balance | | Unamortized Premium (Discount) | | Amortized Cost | | | | Unrealized Gain/ (Loss), net | | Fair Value | | Period- end Weighted Average Yield (1) |
| | | | | | | | | | | | | |
30 year fixed-rate Agency RMBS | 4,722,768 | | | (115,365) | | | 4,607,403 | | | | | 54,334 | | | 4,661,737 | | | 5.26 | % |
| | | | | | | | | | | | | |
Agency-CMO (2) | 619,069 | | | (536,376) | | | 82,693 | | | | | 2,263 | | | 84,956 | | | 9.09 | % |
Non-Agency CMBS | 38,652 | | | (1,472) | | | 37,180 | | | | | (393) | | | 36,787 | | | 8.35 | % |
Non-Agency RMBS (3)(4)(5) | 307,016 | | | (299,012) | | | 8,004 | | | | | 409 | | | 8,413 | | | 8.33 | % |
Total | 5,687,505 | | | (952,225) | | | 4,735,280 | | | | | 56,613 | | | 4,791,893 | | | 5.35 | % |
(1)Period-end weighted average yield is based on amortized cost as of December 31, 2022 and incorporates future prepayment and loss assumptions when appropriate.
(2)All Agency-CMO are Agency IO.
(3)Non-Agency RMBS is 68.6% fixed rate, 30.6% variable rate and 0.8% floating rate based on fair value. Coupon payments on variable rate investments are based upon changes in the underlying hybrid ARM loan coupons, while coupon payments on floating rate investments are based upon a spread to a reference index.
(4)Of the total discount in non-Agency RMBS, $2.1 million is non-accretable calculated using the principal/notional balance and based on estimated future cash flows of the securities.
(5)Non-Agency RMBS includes non-Agency IO which represent 97.1% of principal/notional balance, 41.6% of amortized cost and 35.3% of fair value.
The following table presents the fair value of our available-for-sale securities and securities accounted for under the fair value option by asset type as of March 31, 2023 and December 31, 2022. We have elected the fair value option for all of our RMBS interest-only securities and our MBS purchased on or after September 1, 2016. As of March 31, 2023 and December 31, 2022, approximately 99% of our MBS was accounted for under the fair value option.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2023 | | December 31, 2022 |
$ in thousands | Available-for-sale Securities | | Securities under Fair Value Option | | Total Fair Value | | Available-for-sale Securities | | Securities under Fair Value Option | | Total Fair Value |
| | | | | | | | | | | |
30 year fixed-rate Agency RMBS | — | | | 5,320,942 | | | 5,320,942 | | | — | | | 4,661,737 | | | 4,661,737 | |
| | | | | | | | | | | |
Agency-CMO | — | | | 81,258 | | | 81,258 | | | — | | | 84,956 | | | 84,956 | |
Non-Agency CMBS | 36,624 | | | — | | | 36,624 | | | 36,787 | | | — | | | 36,787 | |
Non-Agency RMBS | 5,638 | | | 2,681 | | | 8,319 | | | 5,667 | | | 2,746 | | | 8,413 | |
Total | 42,262 | | | 5,404,881 | | | 5,447,143 | | | 42,454 | | | 4,749,439 | | | 4,791,893 | |
The components of the carrying value of our MBS portfolio at March 31, 2023 and December 31, 2022 are presented below. Accrued interest receivable on our MBS portfolio, which is recorded within investment related receivable on our condensed consolidated balance sheets, was $23.2 million as of March 31, 2023 (December 31, 2022: $21.3 million).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2023 | | December 31, 2022 |
$ in thousands | MBS | | Interest-Only Securities | | Total | | MBS | | Interest-Only Securities | | Total |
Principal/notional balance | 5,404,033 | | | 900,655 | | | 6,304,688 | | | 4,770,175 | | | 917,330 | | | 5,687,505 | |
Unamortized premium | 5,072 | | | — | | | 5,072 | | | 5,195 | | | — | | | 5,195 | |
Unamortized discount | (167,711) | | | (816,763) | | | (984,474) | | | (126,112) | | | (831,308) | | | (957,420) | |
| | | | | | | | | | | |
Gross unrealized gains (1) | 122,940 | | | 3,971 | | | 126,911 | | | 62,245 | | | 4,605 | | | 66,850 | |
Gross unrealized losses (1) | (1,348) | | | (3,706) | | | (5,054) | | | (7,535) | | | (2,702) | | | (10,237) | |
Fair value | 5,362,986 | | | 84,157 | | | 5,447,143 | | | 4,703,968 | | | 87,925 | | | 4,791,893 | |
(1)Gross unrealized gains and losses includes gains (losses) recognized in net income for securities accounted for under the fair value option as well as gains (losses) for available-for-sale securities which are recognized as adjustments to other comprehensive income. Realization occurs upon sale or settlement of such securities. Further detail on the components of our total gains (losses) on investments, net for the three months ended March 31, 2023 and 2022 is provided below in this Note 4.
The following table summarizes our MBS portfolio according to estimated weighted average life classifications as of March 31, 2023 and December 31, 2022.
| | | | | | | | | | | |
$ in thousands | March 31, 2023 | | December 31, 2022 |
Less than one year | 26,452 | | | 26,593 | |
Greater than one year and less than five years | 10,477 | | | 10,194 | |
Greater than or equal to five years | 5,410,214 | | | 4,755,106 | |
Total | 5,447,143 | | | 4,791,893 | |
The following tables present the estimated fair value and gross unrealized losses of our MBS by length of time that such securities have been in a continuous unrealized loss position at March 31, 2023 and December 31, 2022.
March 31, 2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Less than 12 Months | | 12 Months or More | | Total |
$ in thousands | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities |
| | | | | | | | | | | | | | | | | |
30 year fixed-rate Agency RMBS (1) | 244,788 | | | (471) | | | 3 | | | — | | | — | | | — | | | 244,788 | | | (471) | | | 3 | |
| | | | | | | | | | | | | | | | | |
Agency-CMO (1) | 45,111 | | | (1,959) | | | 9 | | | 7,270 | | | (1,259) | | | 2 | | | 52,381 | | | (3,218) | | | 11 | |
Non-Agency CMBS (2) | 36,623 | | | (847) | | | 3 | | | — | | | — | | | — | | | 36,623 | | | (847) | | | 3 | |
Non-Agency RMBS (3) | 437 | | | (30) | | | 3 | | | 1,387 | | | (488) | | | 9 | | | 1,824 | | | (518) | | | 12 | |
Total | 326,959 | | | (3,307) | | | 18 | | | 8,657 | | | (1,747) | | | 11 | | | 335,616 | | | (5,054) | | | 29 | |
(1)Fair value option has been elected for all Agency securities in an unrealized loss position.
(2)Unrealized losses on non-Agency CMBS are included in accumulated other comprehensive income. These losses are not reflected in an allowance for credit losses based on a comparison of discounted expected cash flows to current amortized cost basis.
(3)Includes non-Agency IO with a fair value of $1.4 million for which the fair value option has been elected. Such securities have unrealized losses of $488,000.
December 31, 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Less than 12 Months | | 12 Months or More | | Total |
$ in thousands | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities |
| | | | | | | | | | | | | | | | | |
30 year fixed-rate Agency RMBS (1) | 929,292 | | | (7,060) | | | 7 | | | — | | | — | | | — | | | 929,292 | | | (7,060) | | | 7 | |
| | | | | | | | | | | | | | | | | |
Agency-CMO (1) | 25,417 | | | (1,645) | | | 6 | | | 2,934 | | | (496) | | | 1 | | | 28,351 | | | (2,141) | | | 7 | |
Non-Agency CMBS (2) | 26,592 | | | (439) | | | 2 | | — | | | — | | | — | | | 26,592 | | | (439) | | | 2 |
Non-Agency RMBS (3) | 349 | | | (36) | | | 2 | | | 1,411 | | | (561) | | | 9 | | | 1,760 | | | (597) | | | 11 | |
Total | 981,650 | | | (9,180) | | | 17 | | | 4,345 | | | (1,057) | | | 10 | | | 985,995 | | | (10,237) | | | 27 | |
(1)Fair value option has been elected for all Agency securities in an unrealized loss position.
(2)Unrealized losses on non-Agency CMBS are included in accumulated other comprehensive income. These losses are not reflected in an allowance for credit losses based on a comparison of discounted expected cash flows to current amortized cost basis.
(3)Includes non-Agency IO with a fair value of $1.4 million for which the fair value option has been elected. Such securities have unrealized losses of $561,000.
The following table summarizes the components of our total gain (loss) on investments, net for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Gross realized gains on sale of MBS | 5,363 | | | — | | | | | |
Gross realized losses on sale of MBS | (19,128) | | | (318,970) | | | | | |
Net unrealized gains (losses) on MBS accounted for under the fair value option | 65,721 | | | (165,467) | | | | | |
Net unrealized gains (losses) on commercial loan | — | | | (124) | | | | | |
Net unrealized gains (losses) on U.S. Treasury securities | — | | | (19,827) | | | | | |
Total gain (loss) on investments, net | 51,956 | | | (504,388) | | | | | |
The following tables present components of interest income recognized on our mortgage-backed and other securities portfolio for the three months ended March 31, 2023 and 2022.
For the three months ended March 31, 2023 | | | | | | | | | | | | | | | | | |
$ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income |
Agency RMBS | 67,483 | | | 14 | | | 67,497 | |
Non-Agency CMBS | 475 | | | 291 | | | 766 | |
Non-Agency RMBS | 290 | | | (134) | | | 156 | |
| | | | | |
Other | 868 | | | — | | | 868 | |
Total | 69,116 | | | 171 | | | 69,287 | |
For the three months ended March 31, 2022
| | | | | | | | | | | | | | | | | |
$ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income |
Agency RMBS | 46,598 | | | (6,928) | | | 39,670 | |
| | | | | |
Non-Agency CMBS | 737 | | | 503 | | | 1,240 | |
Non-Agency RMBS | 330 | | | (151) | | | 179 | |
U.S. Treasury Securities | 560 | | | (16) | | | 544 | |
Other | 4 | | | — | | | 4 | |
Total | 48,229 | | | (6,592) | | | 41,637 | |
Note 5 – Other Assets
The following table summarizes our other assets as of March 31, 2023 and December 31, 2022.
| | | | | | | | | | | |
$ in thousands | March 31, 2023 | | December 31, 2022 |
Investments in unconsolidated ventures | 504 | | | 552 | |
Prepaid expenses and other assets | 1,215 | | | 1,179 | |
Total | 1,719 | | | 1,731 | |
As of December 31, 2022, we were invested in two unconsolidated ventures that were managed by an affiliate of our Manager. Our joint venture whose net assets were denominated in euros was dissolved during the first quarter of 2023. Our remaining unconsolidated venture is in liquidation and plans to sell or settle its remaining investments as expeditiously as possible. Refer to Note 14 - "Commitments and Contingencies" for additional details regarding our commitment to this unconsolidated venture.
Note 6 – Borrowings
We finance the majority of our investment portfolio through repurchase agreements. Our repurchase agreements bear interest at a contractually agreed upon rate and generally have maturities ranging from one to six months. We account for our repurchase agreements as secured borrowings since we maintain effective control of the financed assets. Our repurchase agreements are subject to certain financial covenants. We were in compliance with all of these covenants as of March 31, 2023.
The following tables summarize certain characteristics of our borrowings at March 31, 2023 and December 31, 2022. Refer to Note 7 - "Collateral Positions" for collateral pledged and held under our repurchase agreements.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | March 31, 2023 | | December 31, 2022 |
| | | | Weighted | | | | | | Weighted |
| | Weighted | | Average | | | | Weighted | | Average |
| | Average | | Remaining | | | | Average | | Remaining |
Amount | | Interest | | Maturity | | Amount | | Interest | | Maturity |
Outstanding | | Rate | | (days) | | Outstanding | | Rate | | (days) |
Repurchase Agreements - Agency RMBS | 4,814,700 | | | 4.91 | % | | 52 | | 4,234,823 | | | 4.24 | % | | 28 |
| | | | | | | | | | | |
Total Borrowings | 4,814,700 | | | 4.91 | % | | 52 | | 4,234,823 | | | 4.24 | % | | 28 |
Note 7 - Collateral Positions
The following table summarizes the fair value of collateral that we pledged and held under our repurchase agreements, interest rate swaps and TBAs as of March 31, 2023 and December 31, 2022. Refer to Note 2 - "Summary of Significant Accounting Policies - Fair Value Measurements" of our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 for a description of how we determine fair value. Agency RMBS collateral pledged is included in mortgage-backed securities on our condensed consolidated balance sheets. Cash collateral pledged on centrally cleared interest rate swaps is classified as restricted cash on our condensed consolidated balance sheets. Cash collateral pledged on repurchase agreements and TBAs accounted for as derivatives is classified as due from counterparties on our condensed consolidated balance sheets.
Cash collateral held that is not restricted for use is included in cash and cash equivalents on our condensed consolidated balance sheets and the liability to return the collateral is included in collateral held payable. Non-cash collateral held is only recognized if the counterparty defaults or if we sell the pledged collateral. As of March 31, 2023 and December 31, 2022, we did not recognize any non-cash collateral held on our condensed consolidated balance sheets.
| | | | | | | | | | | |
$ in thousands | As of |
Collateral Pledged | March 31, 2023 | | December 31, 2022 |
Repurchase Agreements: | | | |
Agency RMBS | 5,085,592 | | | 4,439,583 | |
| | | |
Total repurchase agreements collateral pledged | 5,085,592 | | | 4,439,583 | |
Derivative Instruments: | | | |
Cash | 2,983 | | | 1,584 | |
Restricted cash | 127,038 | | | 103,246 | |
Total derivative instruments collateral pledged | 130,021 | | | 104,830 | |
| | | |
Total collateral pledged: | | | |
Agency RMBS | 5,085,592 | | | 4,439,583 | |
Cash | 2,983 | | | 1,584 | |
Restricted cash | 127,038 | | | 103,246 | |
Total collateral pledged | 5,215,613 | | | 4,544,413 | |
| | | |
| As of |
Collateral Held | March 31, 2023 | | December 31, 2022 |
Repurchase Agreements: | | | |
Cash | 221 | | | 4,892 | |
Non-cash collateral | 17,692 | | | 7,216 | |
Total repurchase agreements collateral held | 17,913 | | | 12,108 | |
Derivative instruments: | | | |
Cash | 1,350 | | | — | |
| | | |
Total derivative instruments collateral held | 1,350 | | | — | |
| | | |
Total collateral held: | | | |
Cash | 1,571 | | | 4,892 | |
Non-cash collateral | 17,692 | | | 7,216 | |
Total collateral held | 19,263 | | | 12,108 | |
Repurchase Agreements
Collateral pledged with our repurchase agreement counterparties is segregated in our books and records. The repurchase agreement counterparties have the right to resell and repledge the collateral posted but have the obligation to return the pledged collateral, or substantially the same collateral if agreed to by us, upon maturity of the repurchase agreement. Under the repurchase agreements, the respective lender retains the contractual right to mark the underlying collateral to fair value. We would be required to provide additional collateral to fund margin calls if the value of pledged assets declined. We intend to maintain a level of liquidity that will enable us to meet margin calls.
The ratio of our total repurchase agreements collateral pledged to our total repurchase agreements outstanding was 106% as of March 31, 2023 (December 31, 2022: 105%) based on the fair value of the securities as reported in our condensed consolidated balance sheets.
Interest Rate Swaps
As of March 31, 2023 and December 31, 2022, all of our interest rate swaps were centrally cleared by a registered clearing organization such as the Chicago Mercantile Exchange (“CME”) and LCH Limited (“LCH”) through a Futures Commission Merchant (“FCM”). We are required to pledge initial margin and daily variation margin for our centrally cleared interest rate swaps that is based on the fair value of our contracts as determined by our FCM. Collateral pledged with our FCM is segregated in our books and records and can be in the form of cash or securities. Daily variation margin for centrally cleared interest rate swaps is characterized as settlement of the derivative itself rather than collateral and is recorded as gain (loss) on derivative instruments, net in our condensed consolidated statements of operations. Certain of our FCM agreements include cross default provisions.
TBAs
Our TBAs provide for bilateral collateral pledging based on market value as determined by our counterparties. Collateral pledged with our TBA counterparties is segregated in our books and records and can be in the form of cash or securities. Our counterparties have the right to repledge the collateral posted and have the obligation to return the pledged collateral, or substantially the same collateral, if agreed to by us, as the market value of the contracts changes.
Note 8 – Derivatives and Hedging Activities
The following table summarizes changes in the notional amount of our derivative instruments during 2023.
| | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | Notional Amount as of December 31, 2022 | | Additions | | Settlement, Termination, Expiration or Exercise | | Notional Amount as of March 31, 2023 | | |
Interest Rate Swaps (1) (2) | 8,150,000 | | | 500,000 | | | (525,000) | | | 8,125,000 | | | |
| | | | | | | | | |
TBA Purchase Contracts | 400,000 | | | 1,000,000 | | | (1,100,000) | | | 300,000 | | | |
TBA Sale Contracts | (400,000) | | | (1,000,000) | | | 1,100,000 | | | (300,000) | | | |
Total | 8,150,000 | | | 500,000 | | | (525,000) | | | 8,125,000 | | | |
(1)Does not include interest rate swaps with forward start dates until the date they begin to bear interest. See below for additional detail on our interest rate swaps with forward start dates.
(2)Notional amount as of March 31, 2023 includes $6.3 billion of interest rate swaps whereby we pay interest at a fixed rate and receive interest at a floating rate and $1.8 billion of interest rate swaps whereby we pay interest at a floating rate and receive interest at a fixed rate. Notional amount as of December 31, 2022 includes $5.8 billion of interest rate swaps whereby we pay interest at a fixed rate and receive interest at a floating rate and $2.4 billion of interest rate swaps whereby we pay interest at a floating rate and receive interest at a fixed rate.
Refer to Note 7 - "Collateral Positions" for further information regarding our collateral pledged to and received from our derivative counterparties.
Interest Rate Swaps
Our repurchase agreements are usually settled on a short-term basis ranging from one month to six months. At each settlement date, we typically refinance each repurchase agreement at the market interest rate at that time. Our objectives in using interest rate derivatives are to add stability to interest expense and to manage our exposures to interest rate movements. To accomplish these objectives, we primarily use interest rate swaps as part of our interest rate risk management strategy. Under the terms of the majority of our interest rate swap contracts, we make fixed-rate payments to a counterparty in exchange for the receipt of floating-rate amounts over the life of the agreements without exchange of the underlying notional amount. To
a lesser extent, we also enter into interest rate swap contracts whereby we make floating-rate payments to a counterparty in exchange for the receipt of fixed-rate amounts as part of our overall risk management strategy.
Amounts recorded in accumulated other comprehensive income before we discontinued cash flow hedge accounting for our interest rate swaps are reclassified to interest expense on repurchase agreements on the condensed consolidated statements of operations as interest is accrued and paid on the related repurchase agreements over the remaining life of the interest rate swap agreements. We reclassified $4.5 million as a decrease to interest expense for the three months ended March 31, 2023 (March 31, 2022: $5.2 million as a decrease). As of March 31, 2023, $5.9 million (December 31, 2022: $10.4 million) of unrealized gains on discontinued cash flow hedges, net are still included in accumulated other comprehensive income and are expected to be reclassified as a decrease to interest expense, repurchase agreements over a period of time through December 15, 2023.
As of March 31, 2023 and December 31, 2022, we had interest rate swaps whereby we pay interest at a fixed rate and receive floating interest based on the secured overnight financing rate (“SOFR”) with the following maturities outstanding, excluding interest rate swaps with forward start dates.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of March 31, 2023 |
Maturities | | Notional Amount | | Weighted Average Fixed Pay Rate | | Weighted Average Floating Receive Rate | | Weighted Average Years to Maturity |
Less than 3 years | | 2,050,000 | | | 0.18 | % | | 4.82 | % | | 2.2 |
3 to 5 years | | 1,475,000 | | | 0.27 | % | | 4.82 | % | | 4.5 |
5 to 7 years | | 850,000 | | | 0.38 | % | | 4.82 | % | | 6.0 |
7 to 10 years | | 1,425,000 | | | 0.55 | % | | 4.82 | % | | 7.5 |
Greater than 10 years | | 500,000 | | | 1.92 | % | | 4.82 | % | | 19.0 |
Total | | 6,300,000 | | | 0.45 | % | | 4.82 | % | | 5.8 |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of December 31, 2022 |
Maturities | | Notional Amount | | Weighted Average Fixed Pay Rate | | Weighted Average Floating Receive Rate | | Weighted Average Years to Maturity |
Less than 3 years | | 1,550,000 | | | 0.09 | % | | 4.30 | % | | 2.2 |
3 to 5 years | | 1,475,000 | | | 0.27 | % | | 4.30 | % | | 4.7 |
5 to 7 years | | 850,000 | | | 0.38 | % | | 4.30 | % | | 6.2 |
7 to 10 years | | 1,425,000 | | | 0.55 | % | | 4.30 | % | | 7.8 |
Greater than 10 years | | 500,000 | | | 1.92 | % | | 4.30 | % | | 19.2 |
Total | | 5,800,000 | | | 0.45 | % | | 4.30 | % | | 6.3 |
As of March 31, 2023, we held $475.0 million notional amount of interest rate swaps with forward start dates that will receive floating interest based on SOFR (December 31, 2022: $975.0 million). As of March 31, 2023, these interest rate swaps had a weighted average maturity of 30.3 years (December 31, 2022: 16.5 years) and a weighted average fixed pay rate of 1.33% (December 31, 2022: 0.89%).
As of March 31, 2023 and December 31, 2022, we had interest rate swaps whereby we pay floating interest based on SOFR and receive interest at a fixed rate with the following maturities outstanding, excluding interest rate swaps with forward start dates.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of March 31, 2023 |
Maturities | | Notional Amount | | Weighted Average Floating Pay Rate | | Weighted Average Fixed Receive Rate | | Weighted Average Years to Maturity |
| | | | | | | | |
3 to 5 years | | 350,000 | | | 4.82 | % | | 2.78 | % | | 4.1 |
5 to 7 years | | 1,000,000 | | | 4.82 | % | | 2.67 | % | | 5.9 |
7 to 10 years | | 200,000 | | | 4.82 | % | | 2.66 | % | | 8.2 |
Greater than 10 years | | 275,000 | | | 4.82 | % | | 2.72 | % | | 29.2 |
Total | | 1,825,000 | | | 4.82 | % | | 2.70 | % | | 9.3 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of December 31, 2022 | |
Maturities | | Notional Amounts | | Weighted Average Floating Pay Rate | | Weighted Average Fixed Receive Rate | | Weighted Average Years to Maturity | |
Less than 3 years | | 100,000 | | | 4.30 | % | | 4.90 | % | | 0.9 | |
3 to 5 years | | 550,000 | | | 4.30 | % | | 2.74 | % | | 4.0 | |
5 to 7 years | | 1,125,000 | | | 4.30 | % | | 2.66 | % | | 6.0 | |
7 to 10 years | | 200,000 | | | 4.30 | % | | 2.66 | % | | 8.4 | |
Greater than 10 years | | 375,000 | | | 4.30 | % | | 2.67 | % | | 29.5 | |
Total | | 2,350,000 | | | 4.30 | % | | 2.78 | % | | 9.3 | |
As of March 31, 2023, we held $275.0 million notional amount of interest rate swaps with forward start dates that will pay floating interest based on SOFR (December 31, 2022: $275.0 million). As of March 31, 2023, these interest rate swaps had a weighted average maturity of 15.8 years (December 31, 2022: 16.0 years) and a weighted average fixed receive rate of 2.63% (December 31, 2022: 2.63%).
Currency Forward Contracts
We have historically used currency forward contracts to help mitigate the potential impact of changes in foreign currency exchange rates on our investments denominated in foreign currencies. We recognize realized and unrealized gains and losses associated with the purchases or sales of currency forward contracts in gain (loss) on derivative instruments, net in our condensed consolidated statements of operations. We did not have any currency forward contracts outstanding as of March 31, 2023 or December 31, 2022.
TBAs
We primarily use TBAs that we do not intend to physically settle on the contractual settlement date as an alternative means of investing in and financing Agency RMBS. The following table summarizes certain characteristics of our TBAs accounted for as derivatives as of March 31, 2023 and December 31, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of March 31, 2023 |
| | Notional Amount | | Implied Cost Basis | | Implied Market Value | | Net Carrying Value |
TBA Purchase Contracts (1) | | 300,000 | | | 299,977 | | | 303,393 | | | 3,416 | |
TBA Sale Contracts (2) | | (300,000) | | | (299,048) | | | (303,393) | | | (4,345) | |
Net TBA Derivatives | | — | | | 929 | | | — | | | (929) | |
(1)Net carrying value of TBA purchase contracts includes $3.4 million of derivative assets.
(2)Net carrying value of TBA sales contract includes $4.3 million of derivative liabilities.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of December 31, 2022 |
| | Notional Amount | | Implied Cost Basis | | Implied Market Value | | Net Carrying Value |
TBA Purchase Contracts (1) | | 400,000 | | | 404,144 | | | 402,237 | | | (1,907) | |
TBA Sale Contracts (2) | | (400,000) | | | (402,707) | | | (402,237) | | | 470 | |
Net TBA Derivatives | | — | | | 1,437 | | | — | | | (1,437) | |
(1)Net carrying value of TBA purchase contracts includes $1.9 million of derivative liabilities.
(2)Net carrying value of TBA sales contract includes $642,000 of derivative assets and $172,000 of derivative liabilities.
Tabular Disclosure of the Effect of Derivative Instruments on the Balance Sheet
The table below presents the fair value of our derivative financial instruments, as well as their classification on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.
$ in thousands | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative Assets | | Derivative Liabilities |
| | As of March 31, 2023 | | As of December 31, 2022 | | | | As of March 31, 2023 | | As of December 31, 2022 |
Balance Sheet | | Fair Value | | Fair Value | | Balance Sheet | | Fair Value | | Fair Value |
Interest Rate Swaps Asset | | — | | | 20 | | | Interest Rate Swaps Liability | | 7,946 | | | — | |
| | | | | | | | | | |
TBAs | | 3,416 | | | 642 | | | TBAs | | 4,345 | | | 2,079 | |
Total Derivative Assets | | 3,416 | | | 662 | | | Total Derivative Liabilities | | 12,291 | | | 2,079 | |
The following tables summarize the effect of interest rate swaps, currency forward contracts and TBAs reported in gain (loss) on derivative instruments, net on the condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | Three Months Ended March 31, 2023 |
Derivative not designated as hedging instrument | | Realized gain (loss) on derivative instruments, net | | Contractual net interest income (expense) | | Unrealized gain (loss), net | | Gain (loss) on derivative instruments, net |
Interest Rate Swaps | | (90,949) | | | 54,464 | | | (7,968) | | | (44,453) | |
| | | | | | | | |
| | | | | | | | |
TBAs | | (951) | | | — | | | 509 | | | (442) | |
Total | | (91,900) | | | 54,464 | | | (7,459) | | | (44,895) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | Three Months Ended March 31, 2022 |
Derivative not designated as hedging instrument | | Realized gain (loss) on derivative instruments, net | | Contractual net interest income (expense) | | Unrealized gain (loss), net | | Gain (loss) on derivative instruments, net |
Interest Rate Swaps | | 343,309 | | | 1,284 | | | (11,399) | | | 333,194 | |
| | | | | | | | |
Currency Forward Contracts | | 193 | | | — | | | (41) | | | 152 | |
TBAs | | (60,073) | | | — | | | (34,413) | | | (94,486) | |
Total | | 283,429 | | | 1,284 | | | (45,853) | | | 238,860 | |
Note 9 – Offsetting Assets and Liabilities
Certain of our repurchase agreements and derivative transactions are governed by underlying agreements that generally provide for a right of offset under master netting arrangements (or similar agreements) in the event of default or in the event of bankruptcy of either party to the transactions. Assets and liabilities subject to such arrangements are presented on a gross basis in the condensed consolidated balance sheets.
The following tables present information about the assets and liabilities that are subject to master netting arrangements (or similar agreements) and can potentially be offset on our condensed consolidated balance sheets at March 31, 2023 and December 31, 2022. The daily variation margin payment for centrally cleared interest rate swaps is characterized as settlement of the derivative itself rather than collateral. Our derivative liability of $7.9 million at March 31, 2023 (December 31, 2022: asset of $20,000) related to centrally cleared interest rate swaps is not included in the table below as a result of this characterization of daily variation margin.
As of March 31, 2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Gross Amounts Not Offset with Financial Assets (Liabilities) in the Balance Sheets | | |
$ in thousands
| Gross Amounts of Recognized Assets (Liabilities) | | Gross Amounts Offset in the Balance Sheets | | Net Amounts of Assets (Liabilities) Presented in the Balance Sheets | | Financial Instruments | | Cash Collateral (Received) Pledged | | Net Amount |
Assets | | | | | | | | | | | |
Derivatives (1) (2) | 3,416 | | | — | | | 3,416 | | | (1,450) | | | (1,350) | | | 616 | |
Total Assets | 3,416 | | | — | | | 3,416 | | | (1,450) | | | (1,350) | | | 616 | |
| | | | | | | | | | | |
Liabilities | | | | | | | | | | | |
Derivatives (1) (2) | (4,345) | | | — | | | (4,345) | | | 1,450 | | | 2,895 | | | — | |
Repurchase Agreements (3) | (4,814,700) | | | — | | | (4,814,700) | | | 4,814,700 | | | — | | | — | |
Total Liabilities | (4,819,045) | | | — | | | (4,819,045) | | | 4,816,150 | | | 2,895 | | | — | |
As of December 31, 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Gross Amounts Not Offset with Financial Assets (Liabilities) in the Balance Sheets | | |
$ in thousands
| Gross Amounts of Recognized Assets (Liabilities) | | Gross Amounts Offset in the Balance Sheets | | Net Amounts of Assets (Liabilities) Presented in the Balance Sheets | | Financial Instruments | | Cash Collateral (Received) Pledged | | Net Amount |
Assets | | | | | | | | | | | |
Derivatives (1) (2) | 642 | | | — | | | 642 | | | (642) | | | — | | | — | |
Total Assets | 642 | | | — | | | 642 | | | (642) | | | — | | | — | |
| | | | | | | | | | | |
Liabilities | | | | | | | | | | | |
Derivatives (1) (2) | (2,079) | | | — | | | (2,079) | | | 642 | | | 1,297 | | | (140) | |
Repurchase Agreements (3) | (4,234,823) | | | — | | | (4,234,823) | | | 4,234,823 | | | — | | | — | |
Total Liabilities | (4,236,902) | | | — | | | (4,236,902) | | | 4,235,465 | | | 1,297 | | | (140) | |
(1)Amounts represent derivative assets and derivative liabilities which could potentially be offset against other derivative assets, derivative liabilities and cash collateral pledged or received.
(2)Cash collateral pledged by us on our derivatives was $130.0 million as of March 31, 2023 (December 31, 2022: $104.8 million) of which $127.0 million relates to initial margin pledged on centrally cleared interest rate swaps (December 31, 2022: $103.2 million). Centrally cleared interest rate swaps are excluded from the tables above. We held $1.4 million of cash collateral on our derivatives as of March 31, 2023 (December 31, 2022: none).
(3)The fair value of securities pledged against our borrowings under repurchase agreements was $5.1 billion as of March 31, 2023 (December 31, 2022: $4.4 billion). We held cash collateral of $221,000 under repurchase agreements as of March 31, 2023 (December 31, 2022: $4.9 million).
Note 10 – Fair Value of Financial Instruments
A three-level valuation hierarchy exists for disclosure of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The three levels are defined as follows:
•Level 1 Inputs – Quoted prices for identical instruments in active markets.
•Level 2 Inputs – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
•Level 3 Inputs – Instruments with primarily unobservable value drivers.
The following tables present our assets and liabilities measured at fair value on a recurring basis.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2023 | | |
| Fair Value Measurements Using: | | |
$ in thousands | Level 1 | | Level 2 | | Level 3 | | NAV as a practical expedient (2) | | Total at Fair Value |
Assets: | | | | | | | | | |
Mortgage-backed securities (1) | — | | | 5,447,143 | | | — | | | — | | | 5,447,143 | |
| | | | | | | | | |
Derivative assets | — | | | 3,416 | | | — | | | — | | | 3,416 | |
Other assets | — | | | — | | | — | | | 504 | | | 504 | |
Total assets | — | | | 5,450,559 | | | — | | | 504 | | | 5,451,063 | |
Liabilities: | | | | | | | | | |
Derivative liabilities | — | | | 12,291 | | | — | | | — | | | 12,291 | |
Total liabilities | — | | | 12,291 | | | — | | | — | | | 12,291 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 | | |
| Fair Value Measurements Using: | | |
$ in thousands | Level 1 | | Level 2 | | Level 3 | | NAV as a practical expedient (2) | | Total at Fair Value |
Assets: | | | | | | | | | |
Mortgage-backed securities (1) | — | | | 4,791,893 | | | — | | | — | | | 4,791,893 | |
Derivative assets | — | | | 662 | | | — | | | — | | | 662 | |
Other assets | — | | | — | | | — | | | 552 | | | 552 | |
Total assets | — | | | 4,792,555 | | | — | | | 552 | | | 4,793,107 | |
Liabilities: | | | | | | | | | |
Derivative liabilities | — | | | 2,079 | | | — | | | — | | | 2,079 | |
Total liabilities | — | | | 2,079 | | | — | | | — | | | 2,079 | |
(1)For more detail about the fair value of our MBS, refer to Note 4 - “Mortgage-Backed Securities”.
(2)Investments in unconsolidated ventures are valued using the net asset value (“NAV”) as a practical expedient and are not subject to redemption, although investors may sell or transfer their interest at the approval of the general partner of the underlying funds. As of December 31, 2022, we were invested in two unconsolidated ventures that were managed by an affiliate of our Manager. One of the unconsolidated ventures was dissolved during the first quarter of 2023. As of March 31, 2023, the remaining unconsolidated venture was in liquidation and plans to sell or settle its remaining investments as expeditiously as possible.
The following table presents the carrying value and estimated fair value of our financial instruments that are not carried at fair value on the condensed consolidated balance sheets at March 31, 2023 and December 31, 2022.
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2023 | | December 31, 2022 |
$ in thousands | Carrying Value | | Estimated Fair Value | | Carrying Value | | Estimated Fair Value |
Financial Liabilities | | | | | | | |
Repurchase agreements | 4,814,700 | | | 4,814,103 | | | 4,234,823 | | | 4,233,627 | |
Total | 4,814,700 | | | 4,814,103 | | | 4,234,823 | | | 4,233,627 | |
The estimated fair value of repurchase agreements is a Level 3 fair value measurement based on an expected present value technique. This method discounts future estimated cash flows using rates we determined best reflect current market interest rates that would be offered for repurchase agreements with similar characteristics and credit quality.
Note 11 – Related Party Transactions
Our Manager is at all times subject to the supervision and oversight of our board of directors and has only such functions and authority as we delegate to it. Under the terms of our management agreement, our Manager and its affiliates provide us with our management team, including our officers and appropriate support personnel. Each of our officers is an employee of our Manager or one of its affiliates. We do not have any employees. Our Manager is not obligated to dedicate any of its employees exclusively to us, nor is our Manager obligated to dedicate any specific portion of time to our business. During the three months ended March 31, 2023, we reimbursed our Manager $409,000 (March 31, 2022: $413,000) for costs of support personnel.
Management Fee
We pay our Manager a fee equal to 1.50% of our stockholders' equity per annum. For purposes of calculating the management fee, stockholders' equity is calculated as average month-end stockholders' equity for the prior calendar quarter as determined in accordance with U.S. GAAP. Stockholders' equity may exclude one-time events due to changes in U.S. GAAP and certain non-cash items upon approval by a majority of our independent directors.
We do not pay any management fees on our investments in unconsolidated ventures that are managed by an affiliate of our Manager.
Expense Reimbursement
We are required to reimburse our Manager for operating expenses incurred on our behalf, including directors and officers insurance, accounting services, auditing and tax services, legal services, filing fees, and miscellaneous general and administrative costs. Our reimbursement obligation is not subject to any dollar limitation.
The following table summarizes the costs incurred on our behalf by our Manager for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Incurred costs, prepaid or expensed | 1,394 | | | 1,337 | | | | | |
Incurred costs, charged against equity as a cost of raising capital | — | | | 58 | | | | | |
Total incurred costs, originally paid by our Manager | 1,394 | | | 1,395 | | | | | |
Note 12 – Stockholders’ Equity
Preferred Stock
In May 2022, our board of directors approved a share repurchase program for our Series B and Series C Preferred Stock. During the three months ended March 31, 2023, we did not repurchase any shares of preferred stock. As of March 31, 2023, we had authority to purchase 1,337,634 additional shares of our Series B Preferred Stock and 1,316,470 additional shares of our Series C Preferred Stock under the current share repurchase program.
Holders of our Series B Preferred Stock are entitled to receive dividends at an annual rate of 7.75% of the liquidation preference of $25.00 per share or $1.9375 per share per annum until December 27, 2024. After December 27, 2024, holders are entitled to receive dividends at a floating rate equal to three-month London Interbank Offered Rate (“LIBOR”) plus a spread of 5.18% of the $25.00 liquidation preference per annum. Dividends are cumulative and payable quarterly in arrears.
Holders of our Series C Preferred Stock are entitled to receive dividends at an annual rate of 7.50% of the liquidation preference of $25.00 per share or $1.875 per share per annum until September 27, 2027. After September 27, 2027, holders are entitled to receive dividends at a floating rate equal to three-month LIBOR plus a spread of 5.289% of the $25.00 liquidation preference per annum. Dividends are cumulative and payable quarterly in arrears.
The United Kingdom Financial Conduct Authority, which regulates LIBOR, announced that it will cease to publish three-month USD LIBOR settings on July 1, 2023. We do not currently intend to amend our Series B or Series C Preferred Stock to change the existing USD LIBOR cessation fallback language. We expect our Series B and Series C Preferred Stock to pay floating rate dividends using a SOFR-based rate in place of three-month LIBOR.
We have the option to redeem shares of our Series B Preferred Stock after December 27, 2024 and shares of our Series C Preferred Stock after September 27, 2027 for $25.00 per share, plus any accumulated and unpaid dividends through the date of the redemption. Shares of Series B and Series C Preferred Stock are not redeemable, convertible into or exchangeable for any other property or any other securities of the Company before those times, except under circumstances intended to preserve our qualification as a REIT or upon the occurrence of a change in control.
Common Stock
In May 2022, our board of directors approved a one-for-ten reverse split of outstanding shares of our common stock. The reverse stock split was effected following the close of business on June 3, 2022 (the “Effective Time”). At the Effective Time, every ten issued and outstanding shares of our common stock were converted into one share of our common stock. No fractional shares were issued in connection with the reverse stock split. Instead, each stockholder holding fractional shares received cash, in lieu of such fractional shares, in an amount determined based on the closing price of our common stock at the Effective Time. The reverse stock split applied to all of our outstanding shares of common stock and did not affect any stockholder’s ownership percentage of our common stock, except for changes resulting from the payment of cash for fractional shares.
As of March 31, 2023, we may sell up to 13,069,931 shares of our common stock from time to time in at-the-market or privately negotiated transactions under our equity distribution agreement with placement agents. These shares are registered with the SEC under our shelf registration statement (as amended and/or supplemented). During the three months ended March 31, 2023, we sold 2,930,069 shares of common stock under our equity distribution agreement for proceeds of $35.8 million, net of approximately $482,000 in commissions and fees. We did not sell any shares of common stock under equity distribution agreements during the three months ended March 31, 2022.
During the three months ended March 31, 2023 and 2022, we did not repurchase any shares of our common stock. As of March 31, 2023, we had authority to purchase 1,816,398 shares of our common stock through our common stock share repurchase program.
Accumulated Other Comprehensive Income
The following tables present the components of total other comprehensive income (loss), net and accumulated other comprehensive income (“AOCI”) for the three months ended March 31, 2023 and 2022. The tables exclude gains and losses on MBS that are accounted for under the fair value option.
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2023 |
$ in thousands | Equity method investments | | Available-for-sale securities | | Derivatives and hedging | | Total |
Total other comprehensive income (loss) | | | | | | | |
Unrealized gain (loss) on mortgage-backed securities, net | — | | | (476) | | | — | | | (476) | |
| | | | | | | |
| | | | | | | |
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense | — | | | — | | | (4,494) | | | (4,494) | |
Currency translation adjustments on investment in unconsolidated venture | (10) | | | — | | | — | | | (10) | |
Reclassification of currency translation loss on investment in unconsolidated venture to other investment income (loss), net | 123 | | | — | | | — | | | 123 | |
Total other comprehensive income (loss) | 113 | | | (476) | | | (4,494) | | | (4,857) | |
| | | | | | | |
AOCI balance at beginning of period | (113) | | | 469 | | | 10,405 | | | 10,761 | |
Total other comprehensive income (loss) | 113 | | | (476) | | | (4,494) | | | (4,857) | |
| | | | | | | |
| | | | | | | |
AOCI balance at end of period | — | | | (7) | | | 5,911 | | | 5,904 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2022 |
$ in thousands | Equity method investments | | Available-for-sale securities | | Derivatives and hedging | | Total |
Total other comprehensive income (loss) | | | | | | | |
Unrealized gain (loss) on mortgage-backed securities, net | — | | | (2,421) | | | — | | | (2,421) | |
| | | | | | | |
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense | — | | | — | | | (5,196) | | | (5,196) | |
Currency translation adjustments on investment in unconsolidated venture | (200) | | | — | | | — | | | (200) | |
Total other comprehensive income (loss) | (200) | | | (2,421) | | | (5,196) | | | (7,817) | |
| | | | | | | |
AOCI balance at beginning of period | 424 | | | 6,749 | | | 30,113 | | | 37,286 | |
Total other comprehensive income (loss) | (200) | | | (2,421) | | | (5,196) | | | (7,817) | |
| | | | | | | |
| | | | | | | |
AOCI balance at end of period | 224 | | | 4,328 | | | 24,917 | | | 29,469 | |
Amounts recorded in AOCI before we discontinued cash flow hedge accounting for our interest rate swaps are reclassified to interest expense on repurchase agreements on the condensed consolidated statements of operations as interest is accrued and paid on the related repurchase agreements over the remaining original life of the interest rate swap agreements.
Dividends
The table below summarizes the dividends we declared during the three months ended March 31, 2023 and 2022. Dividends declared per share on our common stock have been retroactively adjusted to reflect our one-for-ten reverse stock split that was effected following the close of business on June 3, 2022.
| | | | | | | | | | | | | | | | | |
$ in thousands, except per share amounts | Dividends Declared |
Series B Preferred Stock | Per Share | | In Aggregate | | Date of Payment |
2023 | | | | | |
| | | | | |
| | | | | |
February 17, 2023 | 0.4844 | | | 2,198 | | | March 27, 2023 |
2022 | | | | | |
| | | | | |
| | | | | |
February 16, 2022 | 0.4844 | | | 3,003 | | | March 28, 2022 |
| | | | | | | | | | | | | | | | | |
$ in thousands, except per share amounts | Dividends Declared |
Series C Preferred Stock | Per Share | | In Aggregate | | Date of Payment |
2023 | | | | | |
| | | | | |
| | | | | |
February 17, 2023 | 0.46875 | | | 3,664 | | | March 27, 2023 |
2022 | | | | | |
| | | | | |
| | | | | |
February 16, 2022 | 0.46875 | | | 5,391 | | | March 28, 2022 |
| | | | | | | | | | | | | | | | | |
$ in thousands, except per share amounts | Dividends Declared |
Common Stock | Per Share | | In Aggregate | | Date of Payment |
2023 | | | | | |
| | | | | |
| | | | | |
March 27, 2023 | 0.40 | | | 16,658 | | | April 27, 2023 |
2022 | | | | | |
| | | | | |
| | | | | |
March 28, 2022 | 0.90 | | | 29,693 | | | April 27, 2022 |
Note 13 – Earnings (Loss) per Common Share
Earnings (loss) per share for the three months ended March 31, 2023 and 2022 is computed as shown in the table below. Common share amounts and earnings (loss) per share have been retroactively adjusted to reflect our one-for-ten reverse stock split that was effected following the close of business on June 3, 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
In thousands, except per share amounts | 2023 | | 2022 | | | | |
Numerator (Income) | | | | | | | |
Basic Earnings: | | | | | | | |
Net income (loss) available to common stockholders | 15,601 | | | (236,816) | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Denominator (Weighted Average Shares) | | | | | | | |
Basic Earnings: | | | | | | | |
Shares available to common stockholders | 39,607 | | | 32,985 | | | | | |
Effect of dilutive securities: | | | | | | | |
Restricted stock awards | 1 | | | — | | | | | |
| | | | | | | |
| | | | | | | |
Dilutive Shares | 39,608 | | | 32,985 | | | | | |
Earnings (loss) per share: | | | | | | | |
Net income (loss) attributable to common stockholders | | | | | | | |
Basic | 0.39 | | | (7.18) | | | | | |
Diluted | 0.39 | | | (7.18) | | | | | |
The following potential weighted average common shares were excluded from diluted earnings per share for the three months ended March 31, 2022 as the effect would be antidilutive: 1,500 for restricted stock awards.
Note 14 – Commitments and Contingencies
Commitments and Contingencies
Commitments and contingencies may arise in the ordinary course of business. Our material off-balance sheet commitments as of March 31, 2023 are discussed below.
As discussed in Note 5 - “Other Assets”, we have invested in an unconsolidated venture that is sponsored by an affiliate of our Manager. The unconsolidated venture is structured as a partnership, and we invested in the partnership as a limited partner. The unconsolidated venture is in liquidation and plans to sell or settle its remaining investments as expeditiously as possible. Until the venture completes its liquidation, we are committed to fund $2.9 million in additional capital to cover future expenses should they occur.
Note 15 – Subsequent Events
Dividends
We declared the following dividends on May 8, 2023: a Series B Preferred Stock dividend of $0.4844 per share payable on June 27, 2023 to our stockholders of record as of June 5, 2023 and a Series C Preferred Stock dividend of $0.46875 per share payable on June 27, 2023 to our stockholders of record as of June 5, 2023.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
In this quarterly report on Form 10-Q, or this "Quarterly Report," we refer to Invesco Mortgage Capital Inc. and its consolidated subsidiaries as "we," "us," "our Company," or "our," unless we specifically state otherwise or the context indicates otherwise. We refer to our external manager, Invesco Advisers, Inc., as our "Manager," and we refer to the indirect parent company of our Manager, Invesco Ltd. together with its consolidated subsidiaries (which does not include us), as "Invesco."
The following discussion should be read in conjunction with our condensed consolidated financial statements and the accompanying notes to our condensed consolidated financial statements, which are included in Item 1 of this Quarterly Report, as well as the information contained in our most recent Form 10-K filed with the Securities and Exchange Commission (the “SEC”).
Forward-Looking Statements
We make forward-looking statements in this Quarterly Report and other filings we make with the SEC within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such statements are intended to be covered by the safe harbor provided by the same. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond our control. These forward-looking statements include information about possible or assumed future results of our business, investment strategies, financial condition, liquidity, results of operations, plans and objectives. When we use the words “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “project,” “forecast” or similar expressions and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would,” and any other statement that necessarily depends on future events, we intend to identify forward-looking statements, although not all forward-looking statements may contain such words. Factors that could cause actual results to differ from those expressed in our forward-looking statements include, but are not limited to:
•the effects of health endemics, including the COVID-19 pandemic;
•unfavorable or changing economic, market or political conditions;
•general volatility of financial markets and the effects of governmental responses, including actions and initiatives of the U.S. governmental agencies and changes to U.S. government policies, actions and initiatives of foreign governmental agencies and central banks, and monetary policy actions of the Federal Reserve, including actions relating to its agency mortgage-backed securities portfolio, and our ability to respond to and comply with such actions, initiatives and changes;
•our business and investment strategy;
•our investment portfolio and expected investments;
•the availability of investment opportunities in mortgage-related, real estate-related and other securities;
•the availability of U.S. Government Agency guarantees with regard to payments of principal and interest on securities;
•the impact of changes in the credit rating of the U.S. government;
•financing and advance rates for our target assets;
•the impact of changes in interest rates and interest rate spreads and the market value of our target assets;
•the potential interest rate mismatches between our target assets and our borrowings used to fund such investments;
•changes to our expected leverage;
•the availability of financing sources, including our ability to obtain additional financing arrangements and the terms of such arrangements;
•the adequacy of our cash flow from operations and borrowings, and our ability to maintain sufficient liquidity to meet our short-term liquidity needs;
•changes in prepayment rates on our target assets;
•the impact of any deficiencies in loss mitigation of third parties and related uncertainty in the timing of collateral disposition;
•our reliance on third parties in connection with services related to our target assets;
•the effects of hedging instruments, including, but not limited to, the degree to which our hedging strategies may or may not protect us from interest rate and foreign currency exchange rate volatility;
•the degree to which derivative contracts expose us to contingent liabilities;
•rates of default or decreased recovery rates on our target assets;
•counterparty defaults;
•modifications to whole loans or loans underlying securities;
•our ability to comply with financial covenants in our financing arrangements;
•disruption of our information technology systems;
•the impact of potential data security breaches or other cyber-attacks or other disruptions;
•changes in governmental regulations, and changes in zoning, insurance, eminent domain and tax law and rates, and similar matters and our ability to respond to such changes;
•our ability to maintain our qualification as a real estate investment trust for U.S. federal income tax purposes;
•our ability to maintain our exception from the definition of “investment company” under the 1940 Act;
•the market price and trading volume of our capital stock;
•our ability to continue to generate taxable income and our ability to continue to make distributions to our stockholders in the future;
•our intention and ability to pay dividends;
•our dependence upon, and the relationship with, our Manager;
•the availability of qualified personnel from our Manager, and our Manager’s continued ability to find and retain such personnel;
•the accuracy of our estimates relating to fair value of our target assets and interest income recognition;
•our understanding of our competition;
•the impact of changes to U.S. GAAP;
•the adequacy of our disclosure controls and procedures and internal controls over financial reporting; and
•market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy.
The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. You should not place undue reliance on these forward-looking statements. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. Some of these factors are described under the headings "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in this Report. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Summary
We are a Maryland corporation primarily focused on investing in, financing and managing mortgage-backed securities (“MBS”) and other mortgage-related assets. Our objective is to provide attractive risk-adjusted returns to our stockholders, primarily through dividends and secondarily through capital appreciation.
As of March 31, 2023, we were invested in:
•residential mortgage-backed securities (“RMBS”) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association (“Ginnie Mae”), or a federally chartered corporation such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”) (collectively “Agency RMBS”);
•commercial mortgage-backed securities (“CMBS”) that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency CMBS”);
•RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency RMBS”);
•to-be-announced securities forward contracts (“TBAs”) to purchase Agency RMBS; and
•other real estate-related financing arrangements.
During the periods presented in this Quarterly Report, we also invested in:
•a commercial mortgage loan; and
•U.S. Treasury securities.
We continuously evaluate new investment opportunities to complement our current investment portfolio by expanding our target assets and portfolio diversification.
We conduct our business through our wholly-owned subsidiary, IAS Operating Partnership L.P. (the “Operating Partnership”). We are externally managed and advised by our Manager, an indirect wholly-owned subsidiary of Invesco.
We have elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the provisions of the Internal Revenue Code of 1986. To maintain our REIT qualification, we are generally required to distribute at least 90% of our REIT taxable income to our stockholders annually. We operate our business in a manner that permits our exclusion from the definition of “Investment Company” under the 1940 Act.
Market Conditions
Macroeconomic factors that affect our business include interest rates, spread premiums, governmental policy initiatives, residential and commercial real estate prices, credit availability, consumer personal income and spending, corporate earnings, employment conditions, financial conditions and inflation.
Of these macroeconomic factors, government policy initiatives, inflation, interest rates and interest rate volatility had the most direct impacts on our performance and financial condition during the first quarter of 2023. Contributing factors included:
• Financial conditions improved during the first two months of the quarter, as credit spreads tightened, equity markets rallied and volatility eased. However, these positive trends reversed in March as the health of the regional banking system came into question amid multiple bank failures. In response, swift action by regulators, including the Federal Reserve, quickly calmed markets and allowed financial conditions to stabilize and end the quarter only slightly tighter.
• Given the uncertainty around the health of the banking system, interest rates rallied during the quarter, as the yield on the 2 year Treasury fell by 40 basis points, to 4.03%, while the yield on the 10 year Treasury decreased by 41 basis points, to 3.47%. The Federal Reserve’s Open Market Committee (“FOMC”) continued its fight against inflation by increasing the Federal Funds target rate twice, taking the target to a range of 4.75% to 5.0%.
• After a strong start to the new year in January, Agency MBS lagged similar duration Treasuries in February and March, resulting in underperformance for the quarter. Lower coupon Agency MBS sharply underperformed those higher in the coupon stack, as lower coupons were negatively impacted by two distinct events during the quarter. First in February by the sharp increase in interest rates as the disinflationary trend in economic data slowed, and second in March by concerns regarding the timing of sales from Silicon Valley Bank and Signature Bank portfolios, which were highly concentrated in lower coupon Agency MBS.
The following market conditions were also notable for the company in the first quarter of 2023:
• Risk assets, with the exception of structured securities, performed well during the quarter. The S&P 500 gained 7.0%, while the NASDAQ was up 16.8%. Likewise, credit spreads across investment grade credit, high yield and emerging
market debt all finished the quarter tighter. Debt backed by commercial real estate was negatively impacted by concerns that regional banks could be forced to sell assets.
• The employment picture remained strong as gains in non-farm payrolls averaged 345,000 per month, for a total of just over one million jobs added during the quarter. The unemployment rate held steady, ending the quarter at 3.5%.
• Year-over-year price growth, as measured by the consumer price index (“CPI”), continued to moderate during the first quarter, declining from 6.5% at year-end to 5.0% at the end of the first quarter. Commodity prices also moderated during the first quarter, with the Commodity Research Bureau commodity index falling 3.6%. Breakeven rates on U.S Treasury inflation-protected securities (“TIPs”), which reflect investors' expectations of future inflation, continue to indicate confidence that the FOMC will be successful at bringing inflation levels significantly lower, as the inflation rate implied by 2 year and 5 year TIPs was 2.68% and 2.48%, respectively, at the end of the quarter.
• CMBS risk premiums increased due to declining real estate values, increased borrowing costs and tighter mortgage lending standards. The pace of property rent growth is slowing and vacancy rates are increasing across many property types. Meanwhile, reevaluation of tenant needs and a corresponding increase in the amount of available sublease space has created unique headwinds for the office sector. CMBS loan delinquencies increased slightly over the quarter. Industrial, multifamily and retail property loan delinquencies declined while the rate of office loan delinquencies increased notably.
• Credit spreads for non-Agency RMBS ended the quarter largely unchanged, as strong performance early in the period was undone by broader risk aversion into quarter end. Although security valuations were driven primarily by market technicals, investors also focused on deterioration in housing fundamentals, particularly with respect to more credit sensitive profiles. Home price declines resulting from historically low affordability have moderated in recent months as borrowing costs stabilized. Meanwhile, low inventory, positive demographic trends, and shifts in housing preferences in favor of single-family properties have provided crucial support to the market. Despite the potential for a slowing economy, borrower defaults are likely to remain contained given strong loan underwriting and high levels of borrower equity.
Outlook
Moving into the second quarter of 2023, pricing in the Federal Funds futures market indicates that the market expects one or two additional target rate increases during the second quarter. While the timing of the end of the FOMC’s tightening cycle remains uncertain, we believe the conclusion of tightening monetary policy and a potential reduction in interest rate volatility combined with compelling valuations and favorable funding conditions will support an attractive investment environment for Agency RMBS in 2023.
Investment Activities
The table below shows the composition of our investment portfolio as of March 31, 2023, December 31, 2022 and March 31, 2022:
| | | | | | | | | | | | | | | | | |
| As of |
$ in thousands | March 31, 2023 | | December 31, 2022 | | March 31, 2022 |
Agency RMBS: | | | | | |
30 year fixed-rate, at fair value | 5,320,942 | | | 4,661,737 | | | 5,861,979 | |
| | | | | |
Agency CMO, at fair value | 81,258 | | | 84,956 | | | 60,818 | |
Non-Agency CMBS, at fair value | 36,624 | | | 36,787 | | | 61,295 | |
Non-Agency RMBS, at fair value | 8,319 | | | 8,413 | | | 8,402 | |
| | | | | |
U.S. Treasury securities, at fair value | — | | | — | | | 482,445 | |
Commercial loan, at fair value | — | | | — | | | 23,391 | |
Investments in unconsolidated ventures | 504 | | | 552 | | | 4,854 | |
Subtotal | 5,447,647 | | | 4,792,445 | | | 6,503,184 | |
TBAs, at implied cost basis (1) | 929 | | | 1,437 | | | 1,549,395 | |
Total investment portfolio, including TBAs | 5,448,576 | | | 4,793,882 | | | 8,052,579 | |
(1)Our presentation of TBAs in the table above represents management's view of our investment portfolio and does not reflect how we record TBAs on our condensed consolidated balance sheets under U.S. GAAP. Under U.S. GAAP, we record TBAs that we do not intend to physically settle on the contractual settlement date as derivative financial instruments. We value TBAs on our condensed consolidated balance sheets at net carrying value, which represents the difference between the fair market value and the implied cost basis of the TBAs. For further details of our U.S GAAP accounting for TBAs, refer to Note 8 “Derivatives and Hedging Activities” in Part I. Item 1 of this report on Form 10-Q. Our TBA dollar roll transactions are a form of off-balance sheet financing. For further information on how management evaluates our at-risk leverage, see Non-GAAP Financial Measures below.
We sold $783.9 million and purchased $1.4 billion of Agency RMBS during the three months ended March 31, 2023. As of March 31, 2023, our holdings of 30 year fixed-rate Agency RMBS represented approximately 98% of our total investment portfolio, including TBAs, versus 97% as of December 31, 2022 and 73% as of March 31, 2022. Our 30 year fixed-rate Agency RMBS holdings as of March 31, 2023, December 31, 2022 and March 31, 2022 consisted of specified pools with coupon distributions as shown in the table below.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | As of |
| | March 31, 2023 | | December 31, 2022 | | March 31, 2022 |
$ in thousands | | Fair Value | | Percentage | | Fair Value | | Percentage | | Fair Value | | Percentage |
2.0% | | — | | | — | % | | — | | | — | % | | 1,911,141 | | | 32.6 | % |
2.5% | | — | | | — | % | | — | | | — | % | | 1,938,205 | | | 33.1 | % |
3.0% | | — | | | — | % | | — | | | — | % | | 2,012,633 | | | 34.3 | % |
| | | | | | | | | | | | |
4.0% | | 770,111 | | | 14.5 | % | | — | | | — | % | | — | | | — | % |
4.5% | | 1,445,923 | | | 27.2 | % | | 1,392,304 | | | 29.9 | % | | — | | | — | % |
5.0% | | 1,539,794 | | | 28.9 | % | | 1,694,939 | | | 36.4 | % | | — | | | — | % |
5.5% | | 1,565,114 | | | 29.4 | % | | 1,574,494 | | | 33.7 | % | | — | | | — | % |
Total 30 year fixed-rate Agency RMBS | | 5,320,942 | | | 100.0 | % | | 4,661,737 | | | 100.0 | % | | 5,861,979 | | | 100.0 | % |
Our purchases of Agency RMBS have been primarily focused on specified pools with attractive prepayment profiles. We seek to capitalize on the impact of prepayments on our investment portfolio by purchasing specified pools with characteristics that optimize borrower incentive to prepay for both our premium and discount priced investments. The table below shows the specified pool characteristics of our 30 year fixed-rate Agency RMBS holdings as of March 31, 2023, December 31, 2022 and March 31, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | As of |
| | March 31, 2023 | | December 31, 2022 | | March 31, 2022 |
$ in thousands | | Fair Value | | Percentage | | Fair Value | | Percentage | | Fair Value | | Percentage |
Specified pool characteristic: | | | | | | | | | | | | |
Geographic location | | 1,566,529 | | | 29.5 | % | | 1,302,391 | | | 27.9 | % | | 2,116,743 | | | 36.1 | % |
Loan balance | | 1,338,150 | | | 25.1 | % | | 1,033,014 | | | 22.2 | % | | 2,180,304 | | | 37.2 | % |
Generic | | — | | | — | % | | 158,230 | | | 3.4 | % | | 372,955 | | | 6.4 | % |
High loan-to-value (“LTV”) ratio | | 956,556 | | | 18.0 | % | | 750,724 | | | 16.1 | % | | 807,451 | | | 13.8 | % |
Low credit score | | 1,459,707 | | | 27.4 | % | | 1,417,378 | | | 30.4 | % | | 384,526 | | | 6.5 | % |
| | | | | | | | | | | | |
Total 30 year fixed-rate Agency RMBS | | 5,320,942 | | | 100.0 | % | | 4,661,737 | | | 100.0 | % | | 5,861,979 | | | 100.0 | % |
We invest in TBAs as an alternative means of investing in and financing Agency RMBS. As of March 31, 2023 and December 31, 2022 the implied cost basis of TBAs did not represent a material amount of our total investment portfolio, versus 19% as of March 31, 2022. We decreased the allocation to TBAs as implied financing rates in the Agency RMBS TBA dollar roll market increased more than those available in the repurchase market for most coupons.
As of March 31, 2023; December 31, 2022 and March 31, 2022 our holdings of non-Agency CMBS represented approximately 1% of our total investment portfolio, including TBAs. Our non-Agency CMBS portfolio is comprised of fixed-rate securities that were rated single-A (or equivalent) or higher by a nationally recognized statistical rating organization as of March 31, 2023. Approximately 72% of non-Agency CMBS were rated double-A (or equivalent) or higher by a nationally recognized statistical rating organization as of March 31, 2023.
As of March 31, 2023; December 31, 2022 and March 31, 2022, our holdings of non-Agency RMBS represented less than 1% of our total investment portfolio, including TBAs.
As of December 31, 2022 and March 31, 2022, we held investments in two unconsolidated ventures that were managed by an affiliate of our Manager. Our joint venture whose net assets were denominated in euros was dissolved during the first quarter of 2023. Our remaining unconsolidated venture is in liquidation and plans to sell or settle its remaining investments as expeditiously as possible. Until the venture completes its liquidation, we are committed to fund $2.9 million in additional capital to cover future expenses should they occur.
Financing and Other Liabilities
We finance the majority of investment portfolio through repurchase agreements. Repurchase agreements are generally settled on a short-term basis, usually from one to six months, and bear interest at rates that are expected to move in close relationship to the secured overnight financing rate (“SOFR”).
The following table presents the amount of collateralized borrowings outstanding under repurchase agreements as of the end of each quarter, the average amount outstanding during the quarter and the maximum balance outstanding during the quarter.
| | | | | | | | | | | | | | | | | |
$ in thousands | Collateralized borrowings under repurchase agreements |
Quarter Ended | Quarter-end balance | | Average quarterly balance (1) | | Maximum balance (2) |
March 31, 2022 | 5,837,420 | | | 6,218,445 | | | 6,636,913 | |
June 30, 2022 | 3,262,530 | | | 4,059,917 | | | 4,902,191 | |
September 30, 2022 | 3,887,291 | | | 3,907,505 | | | 4,165,996 | |
December 31, 2022 | 4,234,823 | | | 3,825,218 | | | 4,234,823 | |
March 31, 2023 | 4,814,700 | | | 4,734,819 | | | 4,814,700 | |
(1)Average quarterly balance for each period is based on month-end balances.
(2)Amount represents the maximum borrowings at month-end during each of the respective periods.
Hedging Instruments
We enter into interest rate swap agreements that are designed to mitigate the effects of changes in interest rates for a portion of our borrowings. Under these swap agreements, we generally pay fixed interest rates and receive floating interest rates indexed to SOFR. To a lesser extent, we also enter into interest rate swap agreements whereby we make floating interest rate payments indexed to SOFR and receive fixed interest rate payments as part of our overall risk management strategy.
We actively manage our interest rate swap portfolio as the size and composition of our investment portfolio changes. During the three months ended March 31, 2023, we terminated existing interest rate swaps with a notional amount of $525.0 million. In addition, one of our forward starting swaps held as of December 31, 2022 with a notional amount of $500.0 million began to bear interest during the three months ended March 31, 2023. The remainder of our forward starting swaps begin to bear interest in July 2023. Daily variation margin payment for interest rate swaps is characterized as settlement of the derivative itself rather than collateral and is recorded as a realized gain or loss in our condensed consolidated statement of operations. We recorded net losses of $44.5 million on interest rate swaps for the three months ended March 31, 2023 primarily due to changes in forward interest rate expectations.
We have historically entered into currency forward contracts to help mitigate the potential impact of changes in foreign currency exchange rates on investments denominated in foreign currencies. We did not have any currency forward contracts outstanding as of March 31, 2023 or December 31, 2022.
Capital Activities
As of March 31, 2023, we may sell up to 13,069,931 shares of our common stock from time to time in at-the-market or privately negotiated transactions under our equity distribution agreement with placement agents. During the three months ended March 31, 2023, we sold 2,930,069 shares of common stock under our equity distribution agreement for proceeds of $35.8 million, net of approximately $482,000 in commissions and fees. During the three months ended March 31, 2022 we did not sell any shares of common stock under equity distribution agreements.
For information on dividends declared during the three months ended March 31, 2023 and 2022, see Note 12 - "Stockholders' Equity" of our condensed consolidated financial statements in Part I. Item 1 of this report on Form 10-Q.
During the three months ended March 31, 2023, we did not repurchase any shares of our common stock.
In May 2022, our board of directors approved a share repurchase program for our Series B and Series C Preferred Stock. We did not repurchase any preferred stock in the three months ended March 31, 2023. As of March 31, 2023, we had authority to purchase 1,337,634 additional shares of our Series B Preferred Stock and 1,316,470 additional shares of our Series C Preferred Stock under the current share repurchase program.
In May 2022, our board of directors approved a one-for-ten reverse split of outstanding shares of our common stock. The reverse stock split was effected following the close of business on June 3, 2022. For all periods presented, common shares and per common share amounts have been adjusted on a retroactive basis to reflect our one-for-ten reverse stock split.
Book Value per Common Share
We calculate book value per common share as follows.
| | | | | | | | | | | |
| As of |
In thousands except per share amounts | March 31, 2023 | | December 31, 2022 |
Numerator (adjusted equity): | | | |
Total equity | 834,115 | | | 804,075 | |
| | | |
Less: Liquidation preference of Series B Preferred Stock | (113,441) | | | (113,441) | |
Less: Liquidation preference of Series C Preferred Stock | (195,412) | | | (195,412) | |
Total adjusted equity | 525,262 | | | 495,222 | |
| | | |
Denominator (number of shares): | | | |
Common stock outstanding | 41,647 | | | 38,711 | |
| | | |
Book value per common share | 12.61 | | | 12.79 | |
Our book value per common share decreased 1.4% as of March 31, 2023 compared to December 31, 2022 due to modest underperformance in higher coupon Agency RMBS as the slowing of the recent disinflationary trend led to an increase in
interest rate volatility. Refer to Item 3. “Quantitative and Qualitative Disclosures About Market Risk” for interest rate risk and its impact on fair value.
Critical Accounting Policies and Estimates
There have been no significant changes to our critical accounting policies and estimates that are disclosed in our most recent Form 10-K for the year ended December 31, 2022.
Recent Accounting Standards
None.
Results of Operations
The table below presents information from our condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands, except share data | 2023 | | 2022 | | | | |
Interest income | | | | | | | |
Mortgage-backed and other securities | 69,287 | | | 41,637 | | | | | |
Commercial loan | — | | | 537 | | | | | |
Total interest income | 69,287 | | | 42,174 | | | | | |
Interest expense | | | | | | | |
Repurchase agreements (1) | 49,726 | | | (2,104) | | | | | |
Total interest expense | 49,726 | | | (2,104) | | | | | |
Net interest income | 19,561 | | | 44,278 | | | | | |
Other income (loss) | | | | | | | |
Gain (loss) on investments, net | 51,956 | | | (504,388) | | | | | |
| | | | | | | |
Equity in earnings (losses) of unconsolidated ventures | 2 | | | 71 | | | | | |
Gain (loss) on derivative instruments, net | (44,895) | | | 238,860 | | | | | |
Other investment income (loss), net | (93) | | | 55 | | | | | |
Total other income (loss) | 6,970 | | | (265,402) | | | | | |
Expenses | | | | | | | |
Management fee – related party | 2,979 | | | 5,274 | | | | | |
General and administrative | 2,089 | | | 2,024 | | | | | |
Total expenses | 5,068 | | | 7,298 | | | | | |
Net income (loss) | 21,463 | | | (228,422) | | | | | |
Dividends to preferred stockholders | (5,862) | | | (8,394) | | | | | |
Net income (loss) attributable to common stockholders | 15,601 | | | (236,816) | | | | | |
Earnings (loss) per share: | | | | | | | |
Net income (loss) attributable to common stockholders | | | | | | | |
Basic | 0.39 | | | (7.18) | | | | | |
Diluted | 0.39 | | | (7.18) | | | | | |
Weighted average number of shares of common stock: | | | | | | | |
Basic | 39,607,354 | | | 32,985,009 | | | | | |
Diluted | 39,608,545 | | | 32,985,009 | | | | | |
(1)Negative interest expense on repurchase agreements in 2022 is due to amortization of net deferred gains on de-designated interest rate swaps that exceeds current period interest expense on repurchase agreements. For further information on amortization of amounts classified in accumulated other comprehensive income before we discontinued hedge accounting, see Note 8 - “Derivatives and Hedging Activities” and Note 12 - “Stockholders' Equity” in Part I. Item 1. of this report on Form 10-Q.
Interest Income and Average Earning Asset Yields
The table below presents information related to our average earning assets and earning asset yields for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Average earning assets (1) | 5,245,291 | | | 7,005,218 | | | | | |
Average earning asset yields (2) | 5.28 | % | | 2.41 | % | | | | |
(1)Average balances for each period are based on weighted month-end balances.
(2)Average earning asset yields for the period were calculated by dividing interest income, including amortization of premiums and discounts, by average earning assets based on the amortized cost of the investments. All yields are annualized.
Our primary source of income is interest earned on our investment portfolio. We had average earning assets of $5.2 billion for the three months ended March 31, 2023 (March 31, 2022: $7.0 billion). The decrease in average earning assets for the three months ended March 31, 2023 compared to 2022 is primarily due to a reduction in the size of our investment portfolio and related repurchase agreement borrowings during 2022 given expectations that elevated market volatility could result in lower valuations on our assets, while maintaining appropriate levels of leverage following declines in stockholders' equity. Average earning asset yields increased for the three months ended March 31, 2023 compared to 2022 primarily due to our rotation into higher yielding Agency RMBS during 2022.
We earned total interest income of $69.3 million for the three months ended March 31, 2023 (March 31, 2022: $42.2 million). Our interest income includes coupon interest and net (premium amortization) discount accretion on mortgage-backed and other securities as well as interest income on our commercial loan as shown in the table below.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Interest Income | | | | | | | |
Mortgage-backed and other securities - coupon interest | 69,116 | | | 48,229 | | | | | |
Mortgage-backed and other securities - net (premium amortization) discount accretion | 171 | | | (6,592) | | | | | |
Mortgage-backed and other securities - interest income | 69,287 | | | 41,637 | | | | | |
Commercial loan | — | | | 537 | | | | | |
Total interest income | 69,287 | | | 42,174 | | | | | |
Mortgage-backed and other securities interest income increased $27.7 million for the three months ended March 31, 2023 compared to 2022 despite lower average earning assets due to a 287 basis point increase in average earning asset yields. Our commercial loan investment was fully repaid in October 2022.
Prepayment Speeds
Our RMBS portfolio is subject to inherent prepayment risk primarily driven by changes in interest rates, which impacts the amount of premium and discount on the purchase of these securities that is recognized into interest income. Expected future prepayment speeds are estimated on a quarterly basis. Generally, in an environment of falling interest rates, prepayment speeds will increase as homeowners are more likely to prepay their existing mortgage and refinance into a lower borrowing rate. In an environment of rising interest rates, prepayment speeds will generally decrease as homeowners are not as incentivized to refinance. If the actual prepayment speed during the period is faster than estimated, the amortization on securities purchased at a premium to par value will be accelerated, resulting in lower interest income recognized. Conversely, for securities purchased at a discount to par value, interest income will be reduced in periods where prepayment speeds were slower than expected.
The following table presents net (premium amortization) discount accretion recognized on our mortgage-backed and other securities portfolio for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Agency RMBS | 14 | | | (6,928) | | | | | |
Non-Agency CMBS | 291 | | | 503 | | | | | |
Non-Agency RMBS | (134) | | | (151) | | | | | |
| | | | | | | |
U.S. Treasury Securities | — | | | (16) | | | | | |
Net (premium amortization) discount accretion | 171 | | | (6,592) | | | | | |
Net discount accretion was $171,000 for the three months ended March 31, 2023 compared to net premium amortization of $6.6 million for the same period in 2022. The change in net (premium amortization) discount accretion for the three months ended March 31, 2023 compared to 2022 was primarily the result of repositioning our Agency RMBS portfolio into securities with lower book prices.
Our interest income is subject to interest rate risk. Refer to Item 3. "Quantitative and Qualitative Disclosures about Market Risk" for more information relating to interest rate risk and its impact on our operating results.
Interest Expense and Cost of Funds
The table below presents information related to our borrowings and cost of funds for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Total average borrowings (1) | 4,737,476 | | | 6,219,694 | | | | | |
Maximum borrowings during the period (2) | 4,814,700 | | | 6,636,913 | | | | | |
Cost of funds (3) | 4.20 | % | | (0.14) | % | | | | |
(1)Average borrowings for each period are based on weighted month-end balances.
(2)Amount represents the maximum borrowings at month-end during each of the respective periods.
(3)Average cost of funds is calculated by dividing annualized interest expense including amortization of net deferred gain (loss) on de-designated interest rate swaps by our average borrowings.
Total average borrowings decreased $1.5 billion in the three months ended March 31, 2023 compared to 2022 primarily due to a reduction in the size of our investment portfolio and related repurchase agreement borrowings during 2022 given expectations that elevated market volatility could result in lower valuations on our assets, while maintaining appropriate levels of leverage following declines in stockholders' equity. Our average cost of funds increased 434 basis points for the three months ended March 31, 2023 compared to 2022 as the FOMC has consistently raised the Federal Funds target rate from a range of 0.0% to 0.25% as of January 1, 2022 to a range of 4.75% to 5.0% as of March 31, 2023.
The table below presents the components of interest expense for the three months ended March 31, 2023 and 2022.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Interest Expense | | | | | | | |
Interest expense on repurchase agreement borrowings | 54,220 | | | 3,092 | | | | | |
Amortization of net deferred (gain) loss on de-designated interest rate swaps | (4,494) | | | (5,196) | | | | | |
Repurchase agreements interest expense | 49,726 | | | (2,104) | | | | | |
Total interest expense | 49,726 | | | (2,104) | | | | | |
Our repurchase agreements interest expense, which equals our total interest expense, increased $51.8 million for the three months ended March 31, 2023 compared to 2022 despite lower average borrowings due to a higher cost of funds.
Our repurchase agreements interest expense as reported in our condensed consolidated statement of operations includes amortization of net deferred gains and losses on de-designated interest rate swaps as summarized in the table above. Amortization of net deferred gains on de-designated interest rate swaps decreased our total interest expense by $4.5 million during the three months ended March 31, 2023 and $5.2 million during the three months ended March 31, 2022. Amounts
recorded in accumulated other comprehensive income before we discontinued cash flow hedge accounting for our interest rate swaps are reclassified to interest expense on repurchase agreements on the condensed consolidated statements of operations as interest is accrued and paid on the related repurchase agreements over the remaining life of the interest rate swap agreements. We expect that the remaining $5.9 million of net deferred gains on de-designated interest rate swaps will be reclassified from accumulated other comprehensive income and recorded as a decrease to interest expense over a period of time through December 15, 2023.
Net Interest Income
The table below presents the components of net interest income for the three months ended March 31, 2023 and 2022:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Interest Income | | | | | | | |
Mortgage-backed and other securities | 69,287 | | | 41,637 | | | | | |
Commercial loan | — | | | 537 | | | | | |
Total interest income | 69,287 | | | 42,174 | | | | | |
Interest Expense | | | | | | | |
Interest expense on repurchase agreement borrowings | 54,220 | | | 3,092 | | | | | |
Amortization of net deferred (gain) loss on de-designated interest rate swaps | (4,494) | | | (5,196) | | | | | |
Repurchase agreements interest expense | 49,726 | | | (2,104) | | | | | |
Total interest expense | 49,726 | | | (2,104) | | | | | |
Net interest income | 19,561 | | | 44,278 | | | | | |
Net interest rate margin | 1.08 | % | | 2.55 | % | | | | |
Our net interest income, which equals interest income less interest expense, totaled $19.6 million for the three months ended March 31, 2023 (March 31, 2022: $44.3 million). Our net interest rate margin, which equals the yield on our average assets for the period less the average cost of funds for the period, was 1.08% for the three months ended March 31, 2023 (March 31, 2022: 2.55%). The decrease in net interest income for the three months ended March 31, 2023 compared to 2022 was primarily due to a higher cost of funds related to increases in the Federal Funds target rate. The decrease in net interest rate margin for the three months ended March 31, 2023 compared to 2022 was primarily due to a higher cost of funds, which was partially offset by our rotation into higher yielding Agency RMBS. Our short-term borrowings are generally more sensitive to changes in interest rates than our investment portfolio, which is largely comprised of 30 year fixed-rate Agency RMBS.
Gain (Loss) on Investments, net
The table below summarizes the components of gain (loss) on investments, net for the three months ended March 31, 2023 and 2022:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Net realized gains (losses) on sale of MBS | (13,765) | | | (318,970) | | | | | |
Net unrealized gains (losses) on MBS accounted for under the fair value option | 65,721 | | | (165,467) | | | | | |
Net unrealized gains (losses) on commercial loan | — | | | (124) | | | | | |
Net unrealized gains (losses) on U.S. Treasury securities | — | | | (19,827) | | | | | |
Total gain (loss) on investments, net | 51,956 | | | (504,388) | | | | | |
During the three months ended March 31, 2023, we sold MBS and realized net losses of $13.8 million (March 31, 2022: net losses of $319.0 million). Net realized losses during the three months ended March 31, 2023 primarily reflect sales of 4.5% and 5.0% coupon Agency RMBS to purchase 4.0% coupon Agency RMBS with similar yields. Net realized losses during the three months ended March 31, 2022 primarily reflect sales of lower yielding Agency RMBS to purchase higher yielding Agency RMBS.
We have elected the fair value option for all of our MBS purchased on or after September 1, 2016. Before September 1, 2016, we had also elected the fair value option for our non-Agency RMBS interest-only securities. Under the fair value option, changes in fair value are recognized in income in the condensed consolidated statements of operations and are reported as a
component of gain (loss) on investments, net. As of March 31, 2023, $5.4 billion (December 31, 2022: $4.7 billion) or 99% (December 31, 2022: 99%) of our MBS are accounted for under the fair value option.
We recorded net unrealized gains on our MBS portfolio accounted for under the fair value option of $65.7 million in the three months ended March 31, 2023 compared to net unrealized losses of $165.5 million in the three months ended March 31, 2022. Net unrealized gains in the three months ended March 31, 2023 were primarily due to improved Agency RMBS valuations as yields on Treasuries decreased. Net unrealized losses in the three months ended March 31, 2022 primarily reflect wider interest rate spreads on our Agency RMBS.
We recorded unrealized losses of $124,000 on our commercial loan investment in the three months ended March 31, 2022. We valued our commercial loan based upon a valuation from an independent pricing service.
We did not hold any U.S. Treasury securities during the three months ended March 31, 2023 . We recorded unrealized losses of $19.8 million on U.S. Treasury securities during the three months ended March 31, 2022 due to rising interest rates.
Equity in Earnings (Losses) of Unconsolidated Ventures
For the three months ended March 31, 2023, we recorded equity in earnings of unconsolidated ventures of $2,000 (March 31, 2022: $71,000). Earnings and losses of unconsolidated ventures are driven primarily by the underlying portfolio investments.
Gain (Loss) on Derivative Instruments, net
We record all derivatives on our condensed consolidated balance sheets at fair value. Changes in the fair value of our derivatives are recorded in gain (loss) on derivative instruments, net in our condensed consolidated statements of operations. Net interest paid or received under our interest rate swaps is also recognized in gain (loss) on derivative instruments, net in our condensed consolidated statements of operations.
The tables below summarize our realized and unrealized gain (loss) on derivative instruments, net for the following periods.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | Three months ended March 31, 2023 |
Derivative not designated as hedging instrument | | Realized gain (loss) on derivative instruments, net | | Contractual net interest income (expense) | | Unrealized gain (loss), net | | Gain (loss) on derivative instruments, net |
Interest Rate Swaps | | (90,949) | | | 54,464 | | | (7,968) | | | (44,453) | |
| | | | | | | | |
| | | | | | | | |
TBAs | | (951) | | | — | | | 509 | | | (442) | |
Total | | (91,900) | | | 54,464 | | | (7,459) | | | (44,895) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | Three months ended March 31, 2022 |
Derivative not designated as hedging instrument | | Realized gain (loss) on derivative instruments, net | | Contractual net interest income (expense) | | Unrealized gain (loss), net | | Gain (loss) on derivative instruments, net |
Interest Rate Swaps | | 343,309 | | | 1,284 | | | (11,399) | | | 333,194 | |
| | | | | | | | |
Currency Forward Contracts | | 193 | | | — | | | (41) | | | 152 | |
TBAs | | (60,073) | | | — | | | (34,413) | | | (94,486) | |
Total | | 283,429 | | | 1,284 | | | (45,853) | | | 238,860 | |
During the three months ended March 31, 2023, we terminated existing interest rate swaps with a notional amount of $525.0 million. In addition, one of our forward starting swaps held as of December 31, 2022 with a notional amount of $500.0 million began to bear interest during the three months ended March 31, 2023. The remainder of our forward starting swaps begin to bear interest in July 2023. We recorded net losses of $44.5 million and net gains of $333.2 million on interest rate swaps for the three months ended March 31, 2023 and 2022, respectively, primarily due to changes in forward interest rate expectations.
As of March 31, 2023, we had $4.8 billion of repurchase agreement borrowings with a weighted average remaining maturity of 52 days. We typically refinance each repurchase agreement at market interest rates upon maturity. We use interest rate swaps to manage our exposure to changing interest rates and add stability to interest rate expense.
As of March 31, 2023 and December 31, 2022, we held the following interest rate swaps whereby we pay fixed rate interest and receive floating rate interest based upon SOFR.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of March 31, 2023 | | As of December 31, 2022 |
Derivative instrument | | Notional Amounts | | Weighted Average Fixed Pay Rate | | Weighted Average Floating Receive Rate | | Weighted Average Years to Maturity | | Notional Amounts | | Weighted Average Fixed Pay Rate | | Weighted Average Floating Receive Rate | | Weighted Average Years to Maturity |
Interest Rate Swaps (1) | | 6,300,000 | | | 0.45 | % | | 4.82 | % | | 5.8 | | 5,800,000 | | | 0.45 | % | | 4.30 | % | | 6.3 |
(1)Excludes $475.0 million notional amount of interest rate swaps with forward start dates as of March 31, 2023 that will receive floating interest based upon SOFR (December 31, 2022: $975.0 million). As of March 31, 2023, these interest rate swaps had a weighted average maturity of 30.3 years (December 31, 2022: 16.5 years) and a weighted average fixed pay rate of 1.33% (December 31, 2022: 0.89%).
As of March 31, 2023 and December 31, 2022, we held the following interest rate swaps whereby we pay floating rate interest based upon SOFR and receive fixed rate interest.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
$ in thousands | | As of March 31, 2023 | | As of December 31, 2022 |
Derivative instrument | | Notional Amounts | | Weighted Average Floating Pay Rate | | Weighted Average Fixed Receive Rate | | Weighted Average Years to Maturity | | Notional Amounts | | Weighted Average Floating Pay Rate | | Weighted Average Fixed Receive Rate | | Weighted Average Years to Maturity |
Interest Rate Swaps (1) | | 1,825,000 | | | 4.82 | % | | 2.70 | % | | 9.3 | | 2,350,000 | | | 4.30 | % | | 2.78 | % | | 9.3 |
(1)Excludes $275.0 million notional amount of interest rate swaps with forward start dates as of March 31, 2023 that will pay floating interest based upon SOFR (December 31, 2022: $275.0 million). As of March 31, 2023, these interest rate swaps had a weighted average maturity of 15.8 years (December 31, 2022: 16.0 years) and a weighted average fixed receive rate of 2.63% (December 31, 2022: 2.63%).
We historically used currency forward contracts to help mitigate the potential impact of changes in foreign currency exchange rates. As of March 31, 2023 and December 31, 2022, we did not have any currency forward contracts outstanding. During the three months ended March 31, 2022 we settled currency forward contracts of €17.6 million or $20.4 million in notional amount related to our investment in an unconsolidated venture and realized a net gain of $193,000.
We primarily use TBAs that we do not intend to physically settle on the contractual settlement date as an alternative means of investing in and financing Agency RMBS. As of March 31, 2023 and December 31, 2022, we did not have a net notional amount of TBAs. We recorded $442,000 and $94.5 million of net realized and unrealized losses on TBAs during the three months ended March 31, 2023 and 2022, respectively. Net realized and unrealized losses on TBAs for the three months ended March 31, 2022 primarily reflect rising interest rates, in addition to wider interest rate spreads on Agency RMBS.
Other Investment Income (Loss), net
Our other investment income (loss), net during the three months ended March 31, 2023 and 2022 consisted of foreign currency transaction gains and losses. Other investment income (loss) for the three months ended March 31, 2023 also includes the reclassification of our foreign currency translation adjustment that was previously recorded in accumulated other comprehensive income related to an unconsolidated venture that was liquidated during the first quarter of 2023.
Expenses
We incurred management fees of $3.0 million for the three months ended March 31, 2023 (March 31, 2022: $5.3 million). Management fees decreased for the three months ended March 31, 2023 compared to the same periods in 2022 due to a lower stockholders' equity management fee base. Refer to Note 11 – "Related Party Transactions" of our condensed consolidated financial statements for a discussion of our relationship with our Manager and a description of how our fees are calculated.
Our general and administrative expenses not covered under our management agreement amounted to $2.1 million for the three months ended March 31, 2023 (March 31, 2022: $2.0 million). General and administrative expenses not covered under our management agreement primarily consist of directors and officers insurance, legal costs, accounting, auditing and tax services, filing fees and miscellaneous general and administrative costs.
Net Income (Loss) attributable to Common Stockholders
For the three months ended March 31, 2023, our net income attributable to common stockholders was $15.6 million (March 31, 2022: $236.8 million net loss attributable to common stockholders) or $0.39 basic and diluted net income per average share available to common stockholders (March 31, 2022: $7.18 basic and diluted net loss per average share available to common stockholders). The change in net income (loss) attributable to common stockholders was primarily due to (i) net gains on investments of $52.0 million in the 2023 period compared to net losses on investments of $504.4 million in the 2022 period; (ii) net losses on derivative instruments of $44.9 million in the 2023 period compared to net gains on derivative instruments of $238.9 million in the 2022 period; and (iii) a $24.7 million decrease in net interest income.
For further information on the changes in net gain (loss) on investments, net gain (loss) on derivative instruments, and changes in net interest income, see preceding discussion under “Gain (Loss) on Investments, net”, “Gain (Loss) on Derivative Instruments, net” and “Net Interest Income”.
Non-GAAP Financial Measures
The table below shows the non-GAAP financial measures we use to analyze our operating results and the most directly comparable U.S. GAAP measures. We believe these non-GAAP measures are useful to investors in assessing our performance as discussed further below.
| | | | | | | | |
Non-GAAP Financial Measure | | Most Directly Comparable U.S. GAAP Measure |
Earnings available for distribution (and by calculation, earnings available for distribution per common share) | | Net income (loss) attributable to common stockholders (and by calculation, basic earnings (loss) per common share) |
Effective interest expense (and by calculation, effective cost of funds) | | Total interest expense (and by calculation, cost of funds) |
Effective net interest income (and by calculation, effective interest rate margin) | | Net interest income (and by calculation, net interest rate margin) |
Economic debt-to-equity ratio | | Debt-to-equity ratio |
The non-GAAP financial measures used by management should be analyzed in conjunction with U.S. GAAP financial measures and should not be considered substitutes for U.S. GAAP financial measures. In addition, the non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures of our peer companies.
Earnings Available for Distribution
Our business objective is to provide attractive risk-adjusted returns to our stockholders, primarily through dividends and secondarily through capital appreciation. We use earnings available for distribution as a measure of our investment portfolio’s ability to generate income for distribution to common stockholders and to evaluate our progress toward meeting this objective. We calculate earnings available for distribution as U.S. GAAP net income (loss) attributable to common stockholders adjusted for (gain) loss on investments, net; realized (gain) loss on derivative instruments, net; unrealized (gain) loss on derivative instruments, net; TBA dollar roll income; foreign currency gains (losses), net and amortization of net deferred (gain) loss on de-designated interest rate swaps.
By excluding the gains and losses discussed above, we believe the presentation of earnings available for distribution provides a consistent measure of operating performance that investors can use to evaluate our results over multiple reporting periods and, to a certain extent, compare to our peer companies. However, because not all of our peer companies use identical operating performance measures, our presentation of earnings available for distribution may not be comparable to other similarly titled measures used by our peer companies. We exclude the impact of gains and losses when calculating earnings available for distribution because (i) when analyzed in conjunction with our U.S. GAAP results, earnings available for distribution provides additional detail of our investment portfolio’s earnings capacity and (ii) gains and losses are not accounted for consistently under U.S. GAAP. Under U.S. GAAP, certain gains and losses are reflected in net income whereas other gains and losses are reflected in other comprehensive income. For example, a portion of our mortgage-backed securities are classified as available-for-sale securities, and we record changes in the valuation of these securities in other comprehensive income on our condensed consolidated balance sheets. We elected the fair value option for our mortgage-backed securities purchased on or after September 1, 2016, and changes in the valuation of these securities are recorded in other income (loss) in our condensed consolidated statements of operations. In addition, certain gains and losses represent one-time events. We may add and have added additional reconciling items to our earnings available for distribution calculation as appropriate.
To maintain our qualification as a REIT, U.S. federal income tax law generally requires that we distribute at least 90% of our REIT taxable income annually, determined without regard to the deduction for dividends paid and excluding net capital
gains. We have historically distributed at least 100% of our REIT taxable income. Because we view earnings available for distribution as a consistent measure of our investment portfolio's ability to generate income for distribution to common stockholders, earnings available for distribution is one metric, but not the exclusive metric, that our board of directors uses to determine the amount, if any, and the payment date of dividends on our common stock. However, earnings available for distribution should not be considered as an indication of our taxable income, a guaranty of our ability to pay dividends or as a proxy for the amount of dividends we may pay, as earnings available for distribution excludes certain items that impact our cash needs.
Earnings available for distribution is an incomplete measure of our financial performance and there are other factors that impact the achievement of our business objective. We caution that earnings available for distribution should not be considered as an alternative to net income (determined in accordance with U.S. GAAP) or as an indication of our cash flow from operating activities (determined in accordance with U.S. GAAP), a measure of our liquidity or as an indication of amounts available to fund our cash needs.
The table below provides a reconciliation of U.S. GAAP net income (loss) attributable to common stockholders to earnings available for distribution for the following periods. | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands, except per share data | 2023 | | 2022 | | | | |
Net income (loss) attributable to common stockholders | 15,601 | | | (236,816) | | | | | |
Adjustments: | | | | | | | |
(Gain) loss on investments, net | (51,956) | | | 504,388 | | | | | |
Realized (gain) loss on derivative instruments, net (1) | 91,900 | | | (283,429) | | | | | |
Unrealized (gain) loss on derivative instruments, net (1) | 7,459 | | | 45,853 | | | | | |
TBA dollar roll income (2) | 697 | | | 13,401 | | | | | |
| | | | | | | |
Foreign currency (gains) losses, net (3) | 93 | | | (55) | | | | | |
Amortization of net deferred (gain) loss on de-designated interest rate swaps (4) | (4,494) | | | (5,196) | | | | | |
Subtotal | 43,699 | | | 274,962 | | | | | |
Earnings available for distribution | 59,300 | | | 38,146 | | | | | |
Basic income (loss) per common share | 0.39 | | | (7.18) | | | | | |
Earnings available for distribution per common share (5) | 1.50 | | | 1.16 | | | | | |
(1)U.S. GAAP gain (loss) on derivative instruments, net on the condensed consolidated statements of operations includes the following components.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Realized gain (loss) on derivative instruments, net | (91,900) | | | 283,429 | | | | | |
Unrealized gain (loss) on derivative instruments, net | (7,459) | | | (45,853) | | | | | |
Contractual net interest income (expense) on interest rate swaps | 54,464 | | | 1,284 | | | | | |
Gain (loss) on derivative instruments, net | (44,895) | | | 238,860 | | | | | |
(2)A TBA dollar roll is a series of derivative transactions where TBAs with the same specified issuer, term and coupon but different settlement dates are simultaneously bought and sold. The TBA settling in the later month typically prices at a discount to the TBA settling in the earlier month. TBA dollar roll income represents the price differential between the TBA price for current month settlement versus the TBA price for forward month settlement. We include TBA dollar roll income in earnings available for distribution because it is the economic equivalent of interest income on the underlying Agency RMBS, less an implied financing cost, over the forward settlement period. TBA dollar roll income is a component of gain (loss) on derivative instruments, net on our condensed consolidated statements of operations.
(3)Foreign currency gains (losses), net includes foreign currency transaction gains and losses and the reclassification of currency translation adjustments that were previously recorded in accumulated other comprehensive income and is included in other investment income (loss), net on the condensed consolidated statements of operations.
(4)U.S. GAAP repurchase agreements interest expense on the condensed consolidated statements of operations includes the following components.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Interest expense on repurchase agreement borrowings | 54,220 | | | 3,092 | | | | | |
Amortization of net deferred (gain) loss on de-designated interest rate swaps | (4,494) | | | (5,196) | | | | | |
Repurchase agreements interest expense | 49,726 | | | (2,104) | | | | | |
(5)Earnings available for distribution per common share is equal to earnings available for distribution divided by the basic weighted average number of common shares outstanding. Earnings available for distribution per common share for the three months ended March 31, 2023 has been retroactively adjusted to reflect our one-for-ten reverse stock split that was effected following the close of business on June 3, 2022.
The table below shows the components of earnings available for distribution for the following periods.
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
$ in thousands | 2023 | | 2022 | | | | |
Effective net interest income (1) | 69,531 | | | 40,366 | | | | | |
TBA dollar roll income | 697 | | | 13,401 | | | | | |
| | | | | | | |
Equity in earnings (losses) of unconsolidated ventures | 2 | | | 71 | | | | | |
| | | | | | | |
Total expenses | (5,068) | | | (7,298) | | | | | |
Subtotal | 65,162 | | | 46,540 | | | | | |
Dividends to preferred stockholders | (5,862) | | | (8,394) | | | | | |
| | | | | | | |
Earnings available for distribution | 59,300 | | | 38,146 | | | | | |
(1)See below for a reconciliation of net interest income to effective net interest income, a non-GAAP measure.
Earnings available for distribution increased during the three months ended March 31, 2023 compared to the same period in 2022 primarily due to an increase in effective net interest income, which was partially offset by a reduction in our TBA notional amount and related TBA dollar roll activity.
Effective Interest Expense / Effective Cost of Funds / Effective Net Interest Income / Effective Interest Rate Margin
We calculate effective interest expense (and by calculation, effective cost of funds) as U.S. GAAP total interest expense adjusted for contractual net interest income (expense) on our interest rate swaps that is recorded as gain (loss) on derivative instruments, net and the amortization of net deferred gains (losses) on de-designated interest rate swaps that is recorded as repurchase agreements interest expense. We view our interest rate swaps as an economic hedge against increases in future market interest rates on our borrowings. We add back the net payments or receipts on our interest rate swap agreements to our total U.S. GAAP interest expense because we use interest rate swaps to add stability to interest expense. We exclude the amortization of net deferred gains (losses) on de-designated interest rate swaps from our calculation of effective interest expense because we do not consider the amortization a current component of our borrowing costs.
We calculate effective net interest income (and by calculation, effective interest rate margin) as U.S. GAAP net interest income adjusted for contractual net interest income (expense) on our interest rate swaps that is recorded as gain (loss) on derivative instruments, net and amortization of net deferred gains (losses) on de-designated interest rate swaps that is recorded as repurchase agreements interest expense.
We believe the presentation of effective interest expense, effective cost of funds, effective net interest income and effective interest rate margin measures, when considered together with U.S. GAAP financial measures, provides information that is useful to investors in understanding our borrowing costs and operating performance.
The following table reconciles total interest expense to effective interest expense and cost of funds to effective cost of funds for the following periods.
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2023 | | 2022 |
$ in thousands | Reconciliation | | Cost of Funds / Effective Cost of Funds | | Reconciliation | | Cost of Funds / Effective Cost of Funds |
Total interest expense | 49,726 | | | 4.20 | % | | (2,104) | | | (0.14) | % |
Add: Amortization of net deferred gain (loss) on de-designated interest rate swaps | 4,494 | | | 0.38 | % | | 5,196 | | | 0.33 | % |
Less: Contractual net interest expense (income) on interest rate swaps recorded as gain (loss) on derivative instruments, net | (54,464) | | | (4.60) | % | | (1,284) | | | (0.08) | % |
Effective interest expense | (244) | | | (0.02) | % | | 1,808 | | | 0.11 | % |
Our effective interest expense and effective cost of funds decreased in the three months ended March 31, 2023 compared to the same period in 2022 despite a $51.8 million increase in total interest expense, which primarily reflects increases in the Federal Funds target rate, due to $54.5 million of contractual net interest income on interest rate swaps compared to $1.3 million for the same period in 2022.
The following table reconciles net interest income to effective net interest income and net interest rate margin to effective interest rate margin for the following periods.
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, |
| 2023 | | 2022 |
$ in thousands | Reconciliation | | Net Interest Rate Margin / Effective Interest Rate Margin | | Reconciliation | | Net Interest Rate Margin / Effective Interest Rate Margin |
Net interest income | 19,561 | | | 1.08 | % | | 44,278 | | | 2.55 | % |
Less: Amortization of net deferred (gain) loss on de-designated interest rate swaps | (4,494) | | | (0.38) | % | | (5,196) | | | (0.33) | % |
| | | | | | | |
Add: Contractual net interest income (expense) on interest rate swaps recorded as gain (loss) on derivative instruments, net | 54,464 | | | 4.60 | % | | 1,284 | | | 0.08 | % |
Effective net interest income | 69,531 | | | 5.30 | % | | 40,366 | | | 2.30 | % |
Our effective net interest income and effective interest rate margin increased in the three months ended March 31, 2023 compared to the same period in 2022 primarily due to higher interest income resulting from our rotation into higher yielding Agency RMBS during 2022. Effective interest expense and effective cost of funds had a minimal impact on effective net interest income and effective interest rate margin as higher U.S. GAAP interest expense was offset by an increase in contractual net interest income on our interest rate swaps.
Economic Debt-to-Equity Ratio
The tables below show the allocation of our stockholders' equity to our target assets, our debt-to-equity ratio, and our economic debt-to-equity ratio as of March 31, 2023 and December 31, 2022. Our debt-to-equity ratio is calculated in accordance with U.S. GAAP and is the ratio of total debt to total stockholders' equity. As of March 31, 2023, approximately 95% of our equity is allocated to Agency RMBS.
We present an economic debt-to-equity ratio, a non-GAAP financial measure of leverage that considers the impact of the off-balance sheet financing of our investments in TBAs that are accounted for as derivative instruments under U.S. GAAP. We include our TBAs at implied cost basis in our measure of leverage because a forward contract to acquire Agency RMBS in the TBA market carries similar risks to Agency RMBS purchased in the cash market and funded with on-balance sheet liabilities. Similarly, a contract for the forward sale of Agency RMBS has substantially the same effect as selling the underlying Agency RMBS and reducing our on-balance sheet funding commitments. We believe that presenting our economic debt-to-equity ratio, when considered together with our U.S. GAAP financial measure of debt-to-equity ratio, provides information that is useful to investors in understanding how management evaluates our at-risk leverage and gives investors a comparable statistic to those of other mortgage REITs who also invest in TBAs and present a similar non-GAAP measure of leverage.
March 31, 2023 | | | | | | | | | | | |
$ in thousands | Agency RMBS | Credit Portfolio (1) | Total |
Mortgage-backed securities | 5,402,200 | | 44,943 | | 5,447,143 | |
| | | |
Cash and cash equivalents (2) | 101,834 | | — | | 101,834 | |
Restricted cash (3) | 127,038 | | — | | 127,038 | |
Derivative assets, at fair value (3) | 3,416 | | — | | 3,416 | |
Other assets | 27,183 | | 758 | | 27,941 | |
Total assets | 5,661,671 | | 45,701 | | 5,707,372 | |
| | | |
Repurchase agreements | 4,814,700 | | — | | 4,814,700 | |
Derivative liabilities, at fair value (3) | 12,291 | | — | | 12,291 | |
Other liabilities | 44,792 | | 1,474 | | 46,266 | |
Total liabilities | 4,871,783 | | 1,474 | | 4,873,257 | |
| | | |
Total stockholders' equity (allocated) | 789,888 | | 44,227 | | 834,115 | |
Debt-to-equity ratio (4) | 6.1 | | — | | 5.8 | |
Economic debt-to-equity ratio (5) | 6.1 | | — | | 5.8 | |
(1)Investments in non-Agency CMBS, non-Agency RMBS and an unconsolidated joint venture are included in credit portfolio.
(2)Cash and cash equivalents is allocated based on our financing strategy for each asset class.
(3)Restricted cash and derivative assets and liabilities are allocated based on our hedging strategy for each asset class.
(4)Debt-to-equity ratio is calculated as the ratio of total repurchase agreements to total stockholders' equity.
(5)Economic debt-to-equity ratio is calculated as the ratio of total repurchase agreements and TBAs at implied cost basis ($929,000 as of March 31, 2023) to total stockholders' equity.
December 31, 2022 | | | | | | | | | | | |
$ in thousands | Agency RMBS | Credit Portfolio (1) | Total |
Mortgage-backed securities | 4,746,693 | | 45,200 | | 4,791,893 | |
Cash and cash equivalents (2) | 175,535 | | — | | 175,535 | |
Restricted cash (3) | 103,246 | | — | | 103,246 | |
Derivative assets, at fair value (3) | 662 | | — | | 662 | |
Other assets | 25,252 | | 807 | | 26,059 | |
Total assets | 5,051,388 | | 46,007 | | 5,097,395 | |
| | | |
Repurchase agreements | 4,234,823 | | — | | 4,234,823 | |
Derivative liabilities, at fair value (3) | 2,079 | | — | | 2,079 | |
Other liabilities | 53,980 | | 2,438 | | 56,418 | |
Total liabilities | 4,290,882 | | 2,438 | | 4,293,320 | |
| | | |
Total stockholders' equity (allocated) | 760,506 | | 43,569 | | 804,075 | |
Debt-to-equity ratio (4) | 5.6 | | — | | 5.3 | |
Economic debt-to-equity ratio (5) | 5.6 | | — | | 5.3 | |
(1)Investments in non-Agency CMBS, non-Agency RMBS and unconsolidated joint ventures are included in credit portfolio.
(2)Cash and cash equivalents is allocated based on our financing strategy for each asset class.
(3)Restricted cash and derivative assets and liabilities are allocated based on our hedging strategy for each asset class.
(4)Debt-to-equity ratio is calculated as the ratio of total repurchase agreements to total stockholders' equity.
(5)Economic debt-to-equity ratio is calculated as the ratio of total repurchase agreements and TBAs at implied cost basis ($1.4 million as of December 31, 2022) to total stockholders' equity.
Liquidity and Capital Resources
Liquidity is a measure of our ability to meet potential cash requirements, including ongoing commitments to pay dividends, fund investments, repay borrowings and fund other general business needs. Our primary sources of funds for liquidity consist of the net proceeds from our common and preferred equity offerings, net cash provided by operating activities, proceeds from repurchase agreements and other financing arrangements and future issuances of equity and/or debt securities.
We currently believe that we have sufficient liquidity and capital resources available for the acquisition of additional investments, repayments on borrowings, margin requirements and the payment of cash dividends as required for continued qualification as a REIT. We generally maintain liquidity to pay down borrowings under repurchase arrangements to reduce borrowing costs and otherwise efficiently manage our long-term investment capital. Because the level of these borrowings can be adjusted on a daily basis, the level of cash and cash equivalents carried on our consolidated balance sheets is significantly less important than our potential liquidity available under borrowing arrangements or through the sale of liquid investments. However, there can be no assurance that we will maintain sufficient levels of liquidity to meet any margin calls.
We held cash, cash equivalents and restricted cash of $228.9 million at March 31, 2023 (March 31, 2022: $497.5 million). Our cash, cash equivalents and restricted cash change due to normal fluctuations in cash balances related to the timing of principal and interest payments, repayments of debt, and asset purchases and sales. Our operating activities provided net cash of $67.2 million for the three months ended March 31, 2023 (March 31, 2022: $40.1 million).
Our investing activities used net cash of $696.9 million in the three months ended March 31, 2023 compared to net cash provided by investing activities of $1.1 billion in the three months ended March 31, 2022. We used cash of $1.4 billion to purchase MBS during the three months ended March 31, 2023 (March 31, 2022: $7.6 billion to purchase MBS and $502.3 million to purchase U.S. Treasury securities). We used cash of $91.9 million to settle derivative contracts in the three months ended March 31, 2023 (March 31, 2022: received cash of $283.4 million). Our primary source of cash from investing activities for the three months ended March 31, 2023 was proceeds from sales of MBS of $783.9 million (March 31, 2022: $8.8 billion from the sales of MBS). We also generated $61.1 million from principal payments of MBS during the three months ended March 31, 2023 (March 31, 2022: $168.3 million).
Our financing activities provided net cash of $579.8 million for the three months ended March 31, 2023 (March 31, 2022: net cash used by financing activities of $1.2 billion). During the three months ended March 31, 2023, we received cash for net proceeds on our repurchase agreements of $579.9 million (March 31, 2022: net cash used of $1.2 billion). We also used cash of
$31.0 million for the three months ended March 31, 2023 to pay dividends (March 31, 2022: $38.1 million). Proceeds from issuance of common stock provided $35.8 million for the three months ended March 31, 2023.
As of March 31, 2023, the average margin requirement (weighted by borrowing amount), or the haircut, under our repurchase agreements was 4.6% for Agency RMBS. The haircuts ranged from a low of 3% to a high of 5% for Agency RMBS. Declines in the value of our securities portfolio can trigger margin calls by our lenders under our repurchase agreements. An event of default or termination event may give our counterparties the option to terminate all repurchase transactions outstanding with us and require any amount due from us to the counterparties to be payable immediately.
Effects of Margin Requirements, Leverage and Credit Spreads
Our securities have values that fluctuate according to market conditions and the market value of our securities will decrease as prevailing interest rates or credit spreads increase. When the value of the securities pledged to secure a repurchase loan decreases to the point where the positive difference between the collateral value and the loan amount is less than the haircut, our lenders may issue a “margin call”, which means that the lender will require us to pay cash or pledge additional collateral. Under our repurchase facilities, our lenders have full discretion to determine the value of the securities we pledge to them. Most of our lenders will value securities based on recent trades in the market. Lenders also issue margin calls as the published current principal balance factors change on the pool of mortgages underlying the securities pledged as collateral when scheduled and unscheduled paydowns are announced monthly.
We experience margin calls and increased collateral requirements in the ordinary course of our business. In seeking to effectively manage the margin requirements established by our lenders, we maintain a position of cash and unpledged securities. We refer to this position as our liquidity. The level of liquidity we have available to meet margin calls is directly affected by our leverage levels, our haircuts and the price changes on our securities. If interest rates increase as a result of a yield curve shift or for another reason or if credit spreads widen, then the prices of our collateral (and our unpledged assets that constitute our liquidity) will decline, we will experience margin calls, and we will seek to use our liquidity to meet the margin calls. There can be no assurance that we will maintain sufficient levels of liquidity to meet any margin calls or increased collateral requirements. If our haircuts increase, our liquidity will proportionately decrease. In addition, if we increase our borrowings, our liquidity will decrease by the amount of additional haircut on the increased level of indebtedness.
We intend to maintain a level of liquidity in relation to our assets that enables us to meet reasonably anticipated margin calls and increased collateral requirements but that also allows us to be substantially invested in securities. We may misjudge the appropriate amount of our liquidity by maintaining excessive liquidity, which would lower our investment returns, or by maintaining insufficient liquidity, which would force us to liquidate assets into unfavorable market conditions and harm our results of operations and financial condition.
We are subject to financial covenants in connection with our lending, derivatives and other agreements we enter into in the normal course of our business. We intend to operate in a manner which complies with all of our financial covenants. Our lending and derivative agreements provide that we may be declared in default of our obligations if our leverage ratio exceeds certain thresholds and we fail to maintain stockholders’ equity or market value above certain thresholds over specified time periods.
Forward-Looking Statements Regarding Liquidity
As of March 31, 2023, we held $5.1 billion of Agency securities that are financed by repurchase agreements. We also had approximately $362.1 million of unencumbered investments and unrestricted cash of $101.8 million as of March 31, 2023. As of March 31, 2023, our known contractual obligations primarily consisted of $4.8 billion of repurchase agreement borrowings with a weighted average remaining maturity of 52 days. We generally intend to refinance the majority of our repurchase agreement borrowings at market rates upon maturity. Repurchase agreement borrowings that are not refinanced upon maturity are typically repaid through the use of cash on hand or proceeds from sales of securities. We are also committed to fund $2.9 million in additional capital to our unconsolidated joint ventures to cover future expenses should they occur.
Based upon our current portfolio and existing borrowing arrangements, we believe that cash flow from operations and available borrowing capacity will be sufficient to enable us to meet anticipated short-term (one year or less) liquidity requirements to fund our investment activities, pay fees under our management agreement, fund our required distributions to stockholders and fund other general corporate expenses.
Our ability to meet our long-term (greater than one year) liquidity and capital resource requirements will be subject to obtaining additional debt financing. We may increase our capital resources by obtaining long-term credit facilities or through public or private offerings of equity or debt securities, possibly including classes of preferred stock, common stock, senior or subordinated notes and convertible notes. Such financing will depend on market conditions for capital raises and our ability to invest such offering proceeds. If we are unable to renew, replace or expand our sources of financing on substantially similar terms, it may have an adverse effect on our business and results of operations.
Exposure to Financial Counterparties
We finance a substantial portion of our investment portfolio through repurchase agreements. Under these agreements, we pledge assets from our investment portfolio as collateral. Additionally, certain counterparties may require us to provide cash collateral in the event the market value of the assets declines to maintain a contractual repurchase agreement collateral ratio. If a counterparty were to default on its obligations, we would be exposed to potential losses to the extent the fair value of collateral pledged by us to the counterparty including any accrued interest receivable on such collateral exceeded the amount loaned to us by the counterparty plus interest due to the counterparty.
As of March 31, 2023, no counterparties held collateral that exceeded the amounts borrowed under the related repurchase agreements by more than $41.7 million, or 5% of our stockholders' equity. The following table summarizes our exposure to counterparties by geographic concentration as of March 31, 2023. The information is based on the geographic headquarters of the counterparty or counterparty's parent company. However, our repurchase agreements are generally denominated in U.S. dollars.
| | | | | | | | | | | | | | | | | |
$ in thousands | Number of Counterparties | | Repurchase Agreement Financing | | Exposure |
North America | 12 | | | 2,527,438 | | | 134,410 | |
Europe (excluding United Kingdom) | 2 | | | 402,511 | | | 18,296 | |
Asia | 3 | | | 1,291,186 | | | 72,187 | |
United Kingdom | 1 | | | 593,565 | | | 26,404 | |
Total | 18 | | | 4,814,700 | | | 251,297 | |
Dividends
To maintain our qualification as a REIT, U.S. federal income tax law generally requires that we distribute at least 90% of our REIT taxable income annually, determined without regard to the deduction for dividends paid and excluding net capital gains. We must pay tax at regular corporate rates to the extent that we annually distribute less than 100% of our REIT taxable income. Before we pay any dividend, whether for U.S. federal income tax purposes or otherwise, we must first meet both our operating requirements and debt service on our repurchase agreements and other debt payable. If our cash available for distribution is less than our REIT taxable income, we could be required to sell assets or borrow funds to make cash distributions, or we may make a portion of the required distribution in the form of a taxable stock distribution or distribution of debt securities.
As discussed above, our distribution requirements are based on REIT taxable income rather than U.S. GAAP net income. The primary differences between our REIT taxable income and U.S. GAAP net income are: (i) unrealized gains and losses on investments that we have elected the fair value option for that are included in current U.S. GAAP income but are excluded from REIT taxable income until realized or settled; (ii) gains and losses on derivative instruments that are included in current U.S. GAAP net income but are excluded from REIT taxable income until realized; and (iii) temporary differences related to amortization of premiums and discounts on investments. For additional information regarding the characteristics of our dividends, refer to Note 12 – "Stockholders' Equity" of our annual report on Form 10-K for the year ended December 31, 2022.
Unrelated Business Taxable Income
We have not engaged in transactions that would result in a portion of our income being treated as unrelated business taxable income.
Other Matters
We believe that we satisfied each of the asset tests in Section 856(c)(4) of the Internal Revenue Code of 1986, as amended (the "Code") for the period ended March 31, 2023, and that our proposed method of operation will permit us to satisfy the asset tests, gross income tests, and distribution and stock ownership requirements for our taxable year that will end on December 31, 2023.
At all times, we intend to conduct our business so that neither we nor our Operating Partnership nor the subsidiaries of our Operating Partnership are required to register as an investment company under the 1940 Act. If we were required to register as an investment company, then our use of leverage would be substantially reduced. Because we are a holding company that conducts our business through our Operating Partnership and the Operating Partnership’s wholly-owned or majority-owned subsidiaries, the securities issued by these subsidiaries that are excepted from the definition of "investment company" under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, together with any other investment securities the Operating Partnership may
own, may not have a combined value in excess of 40% of the value of the Operating Partnership’s total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis, which we refer to as the 40% test. This requirement limits the types of businesses in which we are permitted to engage in through our subsidiaries. In addition, we believe neither we nor the Operating Partnership are considered an investment company under Section 3(a)(1)(A) of the 1940 Act because they do not engage primarily or hold themselves out as being engaged primarily in the business of investing, reinvesting or trading in securities. Rather, through the Operating Partnership’s wholly-owned or majority-owned subsidiaries, we and the Operating Partnership are primarily engaged in the non-investment company businesses of these subsidiaries. IAS Asset I LLC and certain of the Operating Partnership’s other subsidiaries that we may form in the future rely upon the exclusion from the definition of "investment company" under the 1940 Act provided by Section 3(c)(5)(C) of the 1940 Act, which is available for entities "primarily engaged in the business of purchasing or otherwise acquiring mortgages and other liens on and interests in real estate." This exclusion generally requires that at least 55% of each subsidiary’s portfolio be comprised of qualifying assets and at least 80% be comprised of qualifying assets and real estate-related assets (and no more than 20% comprised of miscellaneous assets). We calculate that as of March 31, 2023, we conducted our business so as not to be regulated as an investment company under the 1940 Act.